# ::snt BRCA2 and homologous recombination .
# ::tok BRCA2 and homologous recombination .
# ::alignments 3-4|0.2 2-3|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:23.173
(a / and 
      :op1 (b / BRCA2) 
      :op2 (h / homologou) 
      :op3 (r / recombination))

# ::snt Two recent papers provide new evidence relevant to the role of the breast cancer susceptibility gene BRCA2 in DNA repair .
# ::tok Two recent papers provide new evidence relevant to the role of the breast cancer susceptibility gene BRCA2 in DNA repair .
# ::alignments 19-20|0.1.0.0.0 18-19|0.1.0.0.0.0 16-17|0.1.0.0 15-16|0.1.0 14-15|0.1 13-14|0 12-13|0.0 9-10|0.1.0.0.1 6-7|0.1.0.0.1.0 5-6|0.1.0.0.1.0.0 4-5|0.1.0.0.1.0.0.1 3-4|0.1.0.0.1.0.0.0 2-3|0.1.0.0.1.0.0.0.0 1-2|0.1.0.0.1.0.0.0.0.0 0-1|0.1.0.0.1.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:24.938
(c / cancer 
      :location (b2 / breast) 
      :location (s / susceptibility 
            :mod-of (g / gene 
                  :mod-of (b / BRCA2 
                        :ARG0-of (r / repair-01 
                              :ARG1 (d / DNA)) 
                        :poss-of (r2 / role 
                              :ARG2-of (r3 / relevant-01 
                                    :ARG1 (e / evidence-01 
                                          :ARG1-of (p / provide-01 
                                                :ARG0 (p2 / paper 
                                                      :mod (r4 / recent) 
                                                      :quant 2)) 
                                          :mod (n / new))))))))

# ::snt Moynahan et al provide genetic data indicating a requirement for BRCA2 in homology-dependent ( recombinational ) repair of DNA double-strand breaks .
# ::tok Moynahan et al provide genetic data indicating a requirement for BRCA2 in homology-dependent ( recombinational ) repair of DNA double-strand breaks .
# ::alignments 20-21|0.0 18-19|0 16-17|0.0.0 14-15|0.0.0.0.0.0.0.1 8-9|0.0.0.0 6-7|0.0.0.0.0 5-6|0.0.0.0.0.0 4-5|0.0.0.0.0.0.1 3-4|0.0.0.0.0.0.0 0-3|0.0.0.0.0.0.0.0.0.2+0.0.0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:28.102
(d / DNA 
      :mod-of (b / break-01 
            :ARG1-of (r / repair-01 
                  :ARG1-of (r3 / require-01 
                        :ARG1-of (i / indicate-01 
                              :ARG0 (d2 / data 
                                    :ARG1-of (p / provide-01 
                                          :ARG0 (t / thing 
                                                :name (n / name 
                                                      :op1 "Moynahan" 
                                                      :op2 "et" 
                                                      :op3 "al")) 
                                          :ARG2 (r2 / recombinational)) 
                                    :mod (g / gene)))))))

# ::snt The second paper , by Davies et al , begins to address the mechanism through which BRCA2 makes its contribution to recombinational repair .
# ::tok The second paper , by Davies et al , begins to address the mechanism through which BRCA2 makes its contribution to recombinational repair .
# ::alignments 22-23|0.1.0.0.0.1 19-20|0.1.0.0.0 17-18|0.1.0.0 13-14|0.1.0 11-12|0.1 9-10|0 5-8|0.1.0.0.0.0.0.2+0.1.0.0.0.0.0.1+0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:28.436
(b / begin-01 
      :ARG0 (p / paper) 
      :ARG1 (a / address-02 
            :ARG1 (m2 / mechanism 
                  :ARG0-of (m / make-02 
                        :ARG1 (c / contribute-01 
                              :ARG1 (t / thing 
                                    :name (n / name 
                                          :op1 "Davies" 
                                          :op2 "et" 
                                          :op3 "al")) 
                              :ARG2 (r / repair-01))))))

# ::snt BRCA2 appears to function in recombination via interactions with the major eukaryotic recombinase RAD51 [ 1,2,3 ] .
# ::tok BRCA2 appears to function in recombination via interactions with the major eukaryotic recombinase RAD51 [ 1,2,3 ] .
# ::alignments 12-13|0.1.0 11-12|0.0 10-11|0.2 7-8|0.1.2 5-6|0.1.1 3-4|0.1 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:28.565
(a / appear-02 
      :ARG0 (e / eukaryotic) 
      :ARG1 (f / function-01 
            :ARG0 (r / recombinase) 
            :ARG1 (r2 / recombination) 
            :ARG2 (i / interaction)) 
      :ARG1-of (m / major-02))

# ::snt We briefly review the context in which the two studies were carried out , we comment on the results presented , and we discuss models designed to account for the role of BRCA2 in RAD51 -- mediated repair .
# ::tok We briefly review the context in which the two studies were carried out , we comment on the results presented , and we discuss models designed to account for the role of BRCA2 in RAD51 -- mediated repair .
# ::alignments 37-38|0.2.1.0.0.0.0 36-37|0.2.1.0.0.0.0.0 30-31|0.2.1.0.0.0 27-28|0.2.1.0.0 25-26|0.2.1.0 24-25|0.2.1 23-24|0.2 22-23|0.2.0 21-22|0 19-20|0.1.1.0 18-19|0.1.1.1+0.1.1 15-16|0.1 14-15|0.1.0 11-12|0.0.1.0 9-10|0.0.1.0.0 8-9|0.0.1.0.0.0 4-5|0.0.1 2-3|0.0 1-2|0.0.2 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:30.081
(a2 / and 
      :op1 (r4 / review-01 
            :ARG0 (w3 / we) 
            :ARG1 (c3 / context 
                  :ARG0-of (c2 / carry-out-03 
                        :ARG1 (s / study-01 
                              :quant 2))) 
            :mod (b / briefly)) 
      :op2 (c / comment-01 
            :ARG0 (w2 / we) 
            :ARG3 (t / thing 
                  :ARG1-of (p / present-01) 
                  :ARG2-of (r3 / result-01))) 
      :op3 (d2 / discuss-01 
            :ARG0 (w / we) 
            :ARG1 (m2 / model 
                  :ARG1-of (d / design-01 
                        :ARG3 (a / account-01 
                              :ARG1 (r2 / role 
                                    :ARG1-of (r / repair-01 
                                          :ARG1-of (m / mediate-01))))))))

# ::snt Keywords : breast cancer , homologous recombination .
# ::tok Keywords : breast cancer , homologous recombination .
# ::alignments 6-7|0.0.0.0.0 5-6|0.0.0.0 3-4|0 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:30.142
(c / cancer 
      :mod (b / breast 
            :mod (k / keyword 
                  :op1 (h / homologou 
                        :mod-of (r / recombination)))))

# ::snt BRCA2 was the second breast cancer susceptibility gene to be discovered , and was isolated through positional cloning using data from families with inherited breast cancer [ 4 ] .
# ::tok BRCA2 was the second breast cancer susceptibility gene to be discovered , and was isolated through positional cloning using data from families with inherited breast cancer [ 4 ] .
# ::alignments 27-28|0.0.0.0.0.0.0.0.0 25-26|0 24-25|0.1 23-24|0.0 21-22|0.0.0.0.1 19-20|0.0.0 18-19|0.0.0.0 17-18|0.0.0.0.0 16-17|0.0.0.0.0.1 14-15|0.0.0.0.0.0 12-13|0.0.0.0.0.0.0 10-11|0.0.0.0.0.0.0.0 7-8|0.0.0.0.0.0.0.0.1 6-7|0.0.0.0.0.0.0.0.1.0 5-6|0.0.0.0.0.0.0.0.1.0.0 4-5|0.0.0.0.0.0.0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:32.533
(c / cancer 
      :ARG1-of (i / inherit-01 
            :ARG0 (d / data 
                  :ARG1-of (u / use-01 
                        :ARG0 (c2 / clone-01 
                              :ARG1-of (i2 / isolate-01 
                                    :op2-of (a / and 
                                          :op1 (d2 / discover-01 
                                                :ARG0 4 
                                                :ARG1 (g / gene 
                                                      :mod (s / susceptibility 
                                                            :location-of (c3 / cancer 
                                                                  :location (b2 / breast))))))) 
                              :mod (p / positional)) 
                        :ARG2 (f / family)))) 
      :mod (b / breast))

# ::snt Cells with mutant BRCA2 protein are , like many cancer cells , genetically unstable and accumulate gross chromosomal rearrangements [ 5,6 ] .
# ::tok Cells with mutant BRCA2 protein are , like many cancer cells , genetically unstable and accumulate gross chromosomal rearrangements [ 5,6 ] .
# ::alignments 18-19|0.0.0.0 17-18|0.0.1.0.0.0 16-17|0.0.1.0.0 15-16|0.0.1.0 14-15|0.0.1.0.1 13-14|0.0.1.0.1.0.2+0.0.1.0.1.0 12-13|0.0.1.0.1.0.1 10-11|0.0.1 9-10|0.0.1.1 8-9|0.0.1.2 7-8|0.0 4-5|0 3-4|0.1 2-3|0.0.0 0-1|0.0.1.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:35.651
(p / protein 
      :ARG0-of (r2 / resemble-01 
            :ARG1 (m2 / mutant 
                  :mod (r / rearrangement)) 
            :ARG2 (c2 / cell 
                  :ARG0-of (a / accumulate-01 
                        :ARG1 (g / gross-03 
                              :ARG1 (c / chromosomal)) 
                        :op2-of (a2 / and 
                              :op1 (s / stable-03 
                                    :ARG1 (c4 / cell) 
                                    :mod (g2 / genetics) 
                                    :polarity -))) 
                  :mod (c3 / cancer) 
                  :quant (m / many))) 
      :mod (b / BRCA2))

# ::snt The sequence of this large protein ( 3418 amino acids ) offers very little clue to its function , although there are eight repeated segments ( termed BRC repeats ) in the middle of the protein that are highly conserved among mammalian orthologs [ 7,8 ] .
# ::tok The sequence of this large protein ( 3418 amino acids ) offers very little clue to its function , although there are eight repeated segments ( termed BRC repeats ) in the middle of the protein that are highly conserved among mammalian orthologs [ 7,8 ] .
# ::alignments 42-43|0.0.0.1.1.2.0 41-42|0.0.0.1.0 39-40|0.0.0.0.1 38-39|0.0.0.0.1.1 35-36|0 32-33|0.0 28-29|0.0.0.1.1 27-28|0.0.0.1.1.0.0.0+0.0.0.1.1.0.0+0.0.0.1.1.0 26-27|0.0.0.1.1.2 24-25|0.0.0 23-24|0.0.0.1 22-23|0.0.0.0.1.0 17-18|0.0.0.0 14-15|0.0.0.0.2.1 13-14|0.0.0.0.2.1.0 12-13|0.0.0.0.2.1.0.0 11-12|0.0.0.0.2 9-10|0.0.0.1.1.1.0 8-9|0.0.0.1.1.1.0.0 7-8|0.0.0.1.1.1.1+0.0.0.1.1.1 5-6|0.0.0.0.2.0 4-5|0.0.0.0.2.0.0 3-4|0.0.0.0.2.0.1 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:42.810
(p / protein 
      :part (m2 / middle 
            :ARG1-of (s / segment-01 
                  :ARG0 (f / function-01 
                        :ARG0 (s2 / sequence) 
                        :ARG1-of (c / conserve-01 
                              :ARG0 8 
                              :degree (h / high)) 
                        :ARG3-of (o3 / offer-01 
                              :ARG0 (p2 / protein 
                                    :mod (l2 / large) 
                                    :mod (t2 / this)) 
                              :ARG1 (c2 / clue 
                                    :mod (l / little 
                                          :degree (v / very))))) 
                  :ARG1-of (r2 / repeat-01 
                        :ARG0 (m / mammalian) 
                        :ARG2 (r / repeat-01 
                              :ARG0 (o2 / organization 
                                    :name (n / name 
                                          :op1 "BRC")) 
                              :ARG1 (d / date-entity 
                                    :time-of (a / acid 
                                          :mod (a2 / amino)) 
                                    :year 3418) 
                              :ARG1-of (t / term-01 
                                    :ARG0 (o / ortholog)))))))

# ::snt Breast cancer susceptibility genes and DNA repair .
# ::tok Breast cancer susceptibility genes and DNA repair .
# ::alignments 6-7|0.0.1 5-6|0.0.1.0 4-5|0.0 3-4|0.0.0 2-3|0.0.0.0 1-2|0.0.0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:43.772
(b / breast-01 
      :ARG1 (a / and 
            :op1 (g / gene 
                  :mod (s / susceptibility 
                        :location-of (c / cancer))) 
            :op2 (r / repair-01 
                  :ARG1 (d / DNA))))

# ::snt Following the landmark discovery by Scully et al that the homologous recombinase RAD51 colocalizes at subnuclear sites with BRCA1 [ 9 ] , a number of additional results have provided evidence that both BRCA1 and BRCA2 are involved in recombinational repair of DNA damage .
# ::tok Following the landmark discovery by Scully et al that the homologous recombinase RAD51 colocalizes at subnuclear sites with BRCA1 [ 9 ] , a number of additional results have provided evidence that both BRCA1 and BRCA2 are involved in recombinational repair of DNA damage .
# ::alignments 43-44|0.0.1.0.2.1 42-43|0.0.1.0.2.1.1 40-41|0.0.1.0.2 37-38|0.0.1.0 34-35|0.0.1.0.1 32-33|0.0.1.0.1.0 30-31|0.0.1 29-30|0.0 27-28|0.0.0.0.0+0.0.0.0 26-27|0.0.0.0.0.0 24-25|0.0.0 20-21|0.0.1.0.2.1.0 16-17|0.0.1.0.0 15-16|0.0.1.0.0.0 12-13|0 10-11|0.0.2.0.1 5-8|0.0.2.0.0.0.2+0.0.2.0.0.0.1+0.0.2.0.0.0.0+0.0.2.0.0.0+0.0.2.0.0 3-4|0.0.2.0 2-3|0.0.1.0.2.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:47.471
(r3 / RAD51 
      :ARG2-of (p / provide-01 
            :ARG0 (n / number 
                  :quant-of (t / thing 
                        :ARG2-of (r2 / result-01 
                              :mod (a2 / additional)))) 
            :ARG1 (e / evidence-01 
                  :ARG1 (i / involve-01 
                        :ARG0 (s / site 
                              :location-of (s2 / subnuclear)) 
                        :ARG1 (a / and 
                              :mod (b / both)) 
                        :ARG2 (r / repair-01 
                              :ARG0 (l / landmark) 
                              :ARG1 (d / damage-01 
                                    :ARG0 9 
                                    :ARG1 (d2 / DNA))))) 
            :ARG1-of (f / follow-01 
                  :ARG2 (d3 / discover-01 
                        :ARG0 (t2 / thing 
                              :name (n2 / name 
                                    :op1 "Scully" 
                                    :op2 "et" 
                                    :op3 "al")) 
                        :ARG1 (h / homologou)))))

# ::snt BRCA1 and BRCA2 form discrete nuclear foci during the S phase and after exposure to DNA damaging agents [ 9,10,11 ] .
# ::tok BRCA1 and BRCA2 form discrete nuclear foci during the S phase and after exposure to DNA damaging agents [ 9,10,11 ] .
# ::alignments 17-18|0.0.0.1.0+0.0.0.1+0.0.0 16-17|0.0.0.0 15-16|0 13-14|0.0 12-13|0.0.1 11-12|0.0.1.0 10-11|0.0.1.0.0.3 9-10|0.0.1.0.0.3.0.0+0.0.1.0.0.3.0 6-7|0.0.1.0.0 5-6|0.0.1.0.0.2 4-5|0.0.1.0.0.1 3-4|0.0.1.0.0.0.0 1-2|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:48.086
(d2 / DNA 
      :ARG1-of (e / expose-01 
            :ARG2 (p / person 
                  :ARG0-of (d / damage-01) 
                  :ARG0-of (h / have-org-role-91 
                        :ARG2 (a / agent))) 
            :op1-of (a2 / after 
                  :op1-of (a3 / and 
                        :ARG1-of (f / focus-01 
                              :ARG0 (a4 / and 
                                    :op1 (f2 / form)) 
                              :mod (d3 / discrete) 
                              :mod (n2 / nucleus) 
                              :time (p2 / phase 
                                    :name (n / name 
                                          :op1 "S-400")))))))

# ::snt These foci are probably sites of repair of spontaneous and induced DNA damage [ 12,13,14 ] .
# ::tok These foci are probably sites of repair of spontaneous and induced DNA damage [ 12,13,14 ] .
# ::alignments 12-13|0.0.0.1.0.0 11-12|0.0.0.1.0.0.0 10-11|0.0 9-10|0.0.0 8-9|0.0.0.0 6-7|0.0.0.1.0 4-5|0.0.0.1 3-4|0 1-2|0.0.0.1.1 0-1|0.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:48.469
(p / probable 
      :ARG1-of (i / induce-01 
            :op2-of (a / and 
                  :op1 (s / spontaneous) 
                  :topic-of (s2 / site 
                        :consist-of (r / repair-01 
                              :ARG1 (d / damage-01 
                                    :ARG0 (d2 / DNA))) 
                        :domain (f / focus-01 
                              :mod (t / this))))))

# ::snt Cell lines defective in either BRCA1 or BRCA2 are sensitive to damaging agents that form double-strand breaks ( DSBs ) , as are other cell lines defective in recombinational repair ( reviewed in [ 15 ] ) .
# ::tok Cell lines defective in either BRCA1 or BRCA2 are sensitive to damaging agents that form double-strand breaks ( DSBs ) , as are other cell lines defective in recombinational repair ( reviewed in [ 15 ] ) .
# ::alignments 34-35|0.0.0.0.0 31-32|0.0.0.2.0 29-30|0.0.0.0.1 26-27|0.0.0.2.0.1.0.0 25-26|0.0.0.2.0.1.0 24-25|0.0.0.2.0.1 23-24|0.0.0.2.0.1.0.1 18-19|0.0.0.0.1.0 16-17|0.0.0.2 14-15|0.0.0.1 12-13|0.0.1+0.0+0.0.0 11-12|0.0.0.0 9-10|0.0.0.3 6-7|0 4-5|0.1 2-3|0.2 1-2|0.0.0.3.0 0-1|0.0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:50.818
(o2 / or 
      :ARG1-of (h / have-org-role-91 
            :ARG0 (p / person 
                  :ARG0-of (d3 / damage-01 
                        :ARG1 15 
                        :purpose (r2 / repair-01 
                              :ARG0 (d2 / dsb))) 
                  :ARG0-of (f / form) 
                  :ARG0-of (b / break-01 
                        :ARG1 (r / review-01 
                              :ARG0 (c2 / cell) 
                              :ARG1 (c / cell 
                                    :mod-of (l / line 
                                          :location (d / defective) 
                                          :mod (o / other))))) 
                  :ARG1-of (s / sensitive-03 
                        :ARG0 (l2 / line))) 
            :ARG2 (a / agent)) 
      :mod (e / either) 
      :op1 (d4 / defective))

# ::snt BRCA2 interacts with the RAD51 recombinase via direct protein-protein contacts [ 16,17,18,19 ] .
# ::tok BRCA2 interacts with the RAD51 recombinase via direct protein-protein contacts [ 16,17,18,19 ] .
# ::alignments 9-10|0.0.0 7-8|0.0.0.0 5-6|0.0 4-5|0.0.1 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:50.932
(i / interact-01 
      :ARG1 (r / recombinase 
            :beneficiary (c / contact-01 
                  :ARG1-of (d / direct-02)) 
            :mod (r2 / RAD51)))

# ::snt Biochemical analysis also showed interaction between BRCA1 and RAD51 , although these detected interactions may have been indirect [ 9 ] .
# ::tok Biochemical analysis also showed interaction between BRCA1 and RAD51 , although these detected interactions may have been indirect [ 9 ] .
# ::alignments 19-20|0.0.0 17-18|0.0.2.0.0 14-15|0.0.2.0 13-14|0.0.2.0.0.0 12-13|0.0.2.0.0.0.0 11-12|0.0.2.0.0.0.1 7-8|0.0.2 4-5|0.1 3-4|0 2-3|0.2 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:53.399
(s / show-01 
      :ARG0 (a3 / analyze-01 
            :ARG1 9 
            :manner (b / biochemical) 
            :op1-of (a / and 
                  :op2 (p / possible-01 
                        :ARG1 (d / direct-02 
                              :ARG1 (i / interaction 
                                    :ARG1-of (d2 / detect-01) 
                                    :mod (t / this)))))) 
      :ARG1 (i2 / interact-01) 
      :mod (a2 / also))

# ::snt The BRC repeats of BRCA2 are responsible for direct RAD51 interaction .
# ::tok The BRC repeats of BRCA2 are responsible for direct RAD51 interaction .
# ::alignments 10-11|0.1 8-9|0.1.0 6-7|0 4-5|0.0.1 2-3|0.0 1-2|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:53.818
(r / responsible-01 
      :ARG0 (r2 / repeat-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "BRC")) 
            :ARG1 (b / BRCA2)) 
      :ARG1 (i / interact-01 
            :ARG1-of (d / direct-02)))

# ::snt Cells lacking BRCA1/2 fail to form damage-induced subnuclear RAD51 foci with normal efficiency , suggesting that these proteins are required for the formation of recombinase complexes at the sites of DNA damage [ 20,21 ] .
# ::tok Cells lacking BRCA1/2 fail to form damage-induced subnuclear RAD51 foci with normal efficiency , suggesting that these proteins are required for the formation of recombinase complexes at the sites of DNA damage [ 20,21 ] .
# ::alignments 31-32|0.0 30-31|0 28-29|0.0.0.1.1 25-26|0.0.0.0 22-23|0.0.0 19-20|0.0.0.1 17-18|0.0.0.1.3 16-17|0.0.0.1.3.0 14-15|0.0.0.1.2 12-13|0.0.0.1.0.0.0.0.1 11-12|0.0.0.1.0.0.0.0.1.0 9-10|0.0.0.1.0.0.0.0 8-9|0.0.0.1.0.0.0.0.0 7-8|0.0.0.1.0.0.0.0.0.0 6-7|0.0.0.1.0.0.0.0.2 5-6|0.0.0.1.0.0.0 3-4|0.0.0.1.0.0 1-2|0.0.0.1.0.1 0-1|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:55.511
(d2 / DNA 
      :ARG0-of (d / damage-01 
            :ARG1 (f / form-01 
                  :ARG1 (c / complex) 
                  :purpose-of (r / require-01 
                        :ARG0 (c2 / cell 
                              :ARG0-of (f4 / fail-01 
                                    :ARG2 (f3 / form-01 
                                          :ARG1 (f2 / focus-01 
                                                :ARG1 (r2 / RAD51 
                                                      :mod (s3 / subnuclear)) 
                                                :ARG1-of (e / efficient-01 
                                                      :ARG1-of (n / normal-02)) 
                                                :mod (d3 / damage-induc)))) 
                              :ARG1-of (l / lack-01)) 
                        :ARG1 (s / site) 
                        :ARG1-of (s2 / suggest-01) 
                        :ARG2 (p / protein 
                              :mod (t / this))))))

# ::snt Finally , genetic measurements of recombination frequency have shown that Brca1 - / - embryonic stem ( ES ) cells are deficient in recombinational DSB repair [ 22,23 ] .
# ::tok Finally , genetic measurements of recombination frequency have shown that Brca1 - / - embryonic stem ( ES ) cells are deficient in recombinational DSB repair [ 22,23 ] .
# ::alignments 25-26|0.0.2 24-25|0.0.2.1.0.0+0.0.2.1.0+0.0.2.1 21-22|0.1 19-20|0.1.0 17-18|0.1.1 15-16|0.1.0.0 14-15|0.1.0.0.0 12-13|0.0.0 8-9|0 6-7|0.0.1 5-6|0.0.1.0 3-4|0.0 2-3|0.0.3 0-1|0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:35:56.442
(s3 / show-01 
      :ARG0 (m / measure-01 
            :ARG0 (s2 / slash) 
            :ARG1 (f / frequency 
                  :mod (r2 / recombination)) 
            :ARG2-of (r / repair-01 
                  :ARG0 (f2 / final) 
                  :ARG1 (o / organization 
                        :name (n / name 
                              :op1 "DSB"))) 
            :mod (g / gene)) 
      :ARG1 (d / deficient 
            :domain (c / cell 
                  :mod (s / stem 
                        :mod (e2 / embryonic))) 
            :domain (e / e)))

# ::snt The similarity between phenotypes associated with BRCA1 and BRCA2 deficiency , together with data showing a similar effect of DNA damage on distribution of BRCA1 and BRCA2 in repair-proficient cells , led to the hypothesis that BRCA2 , like BRCA1 , is required for efficient recombinational repair .
# ::tok The similarity between phenotypes associated with BRCA1 and BRCA2 deficiency , together with data showing a similar effect of DNA damage on distribution of BRCA1 and BRCA2 in repair-proficient cells , led to the hypothesis that BRCA2 , like BRCA1 , is required for efficient recombinational repair .
# ::alignments 46-47|0.2.0.0.0.0 44-45|0.2.0.0.0.0.0 42-43|0.2.0.0.0 38-39|0.2.0.0.0.1 34-35|0.2.0.0.1 31-32|0.2.0.0 29-30|0.2.2 25-26|0.2.1 22-23|0.2 20-21|0.1.0 19-20|0.1.0.0 17-18|0.1 16-17|0.1.1 14-15|0 13-14|0.0 11-12|0.2.1.0 9-10|0.2.0.3 8-9|0.2.0.2 7-8|0.2.0 6-7|0.2.0.1.1 4-5|0.2.0.1 3-4|0.2.0.1.0 1-2|0.2.0.4 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:02.538
(s / show-01 
      :ARG1 (d4 / data) 
      :ARG2 (e2 / effect-03 
            :ARG0 (d2 / damage-01 
                  :ARG1 (d3 / DNA)) 
            :ARG1-of (r4 / resemble-01)) 
      :purpose (d / distribute-01 
            :ARG0 (a2 / and 
                  :ARG0-of (l / lead-02 
                        :ARG1 (r2 / require-01 
                              :ARG1 (r / repair-01 
                                    :ARG1-of (e / efficient-01)) 
                              :manner (r3 / resemble-01)) 
                        :ARG2 (h / hypothesi)) 
                  :op1 (a3 / associate-01 
                        :ARG1 (p / phenotyp) 
                        :ARG2 (b2 / BRCA1)) 
                  :op2 (b / BRCA2) 
                  :op3 (d5 / deficiency) 
                  :topic-of (s2 / similarity)) 
            :ARG1 (a / and 
                  :mod (t / together)) 
            :ARG2 (c / cell)))

# ::snt The paper by Moynahan et al [ 24 ] provides important support for this hypothesis .
# ::tok The paper by Moynahan et al [ 24 ] provides important support for this hypothesis .
# ::alignments 14-15|0.1.1 13-14|0.1.1.0 11-12|0.1 10-11|0.1.2 9-10|0 7-8|0.1.1.1 3-6|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:03.055
(p / provide-01 
      :ARG0 (t2 / thing 
            :name (n / name 
                  :op1 "Moynahan" 
                  :op2 "et" 
                  :op3 "al")) 
      :ARG1 (s / support-01 
            :ARG0 (p2 / paper) 
            :ARG1 (h / hypothesi 
                  :mod (t / this) 
                  :mod 24) 
            :mod (i / important)))

# ::snt Measuring DSB-induced recombination frequency in BRCA2-defective cells .
# ::tok Measuring DSB-induced recombination frequency in BRCA2-defective cells .
# ::alignments 6-7|0.1 3-4|0 2-3|0.2 1-2|0.3 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:03.170
(f / frequency 
      :ARG1-of (m / measure-01) 
      :location (c / cell) 
      :mod (r / recombination) 
      :mod (d / dsb-induc))

# ::snt Pierce et al have designed a set of recombination substrates for measuring the level of homologous recombination in vivo ( Fig. 1 ) [ 25 ] .
# ::tok Pierce et al have designed a set of recombination substrates for measuring the level of homologous recombination in vivo ( Fig. 1 ) [ 25 ] .
# ::alignments 24-25|0.0.0.0.0 21-22|0.0.0.0.1.2 20-21|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 18-19|0 16-17|0.0 15-16|0.0.0.0.1.1.0.1 13-14|0.0.0 11-12|0.0.0.0 9-10|0.0.0.0.1.1.0 8-9|0.0.0.0.1.1.0.0 6-7|0.0.0.0.1.1 4-5|0.0.0.0.1 0-3|0.0.0.0.1.0.0.2+0.0.0.0.1.0.0.1+0.0.0.0.1.0.0.0+0.0.0.0.1.0.0+0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:06.754
(v / vivo 
      :location-of (r / recombination 
            :mod-of (l / level 
                  :ARG1-of (m / measure-01 
                        :ARG0 25 
                        :ARG2-of (d / design-01 
                              :ARG0 (t / thing 
                                    :name (n2 / name 
                                          :op1 "Pierce" 
                                          :op2 "et" 
                                          :op3 "al")) 
                              :ARG1 (s2 / set 
                                    :consist-of (s / substrat 
                                          :mod (r2 / recombination) 
                                          :op1 (h / homologou))) 
                              :op1-of 1)) 
                  :location (c / country 
                        :name (n / name 
                              :op1 "Fig.")))))

# ::snt The DNA substrate contains a pair of mutated GFP genes ( GFP encodes the easily detected green fluorescent protein ) , one of which contains a restriction site for I-SceI , a yeast intron encoded endonuclease with an 18 base pair recognition site .
# ::tok The DNA substrate contains a pair of mutated GFP genes ( GFP encodes the easily detected green fluorescent protein ) , one of which contains a restriction site for I-SceI , a yeast intron encoded endonuclease with an 18 base pair recognition site .
# ::alignments 42-43|0.1.0.1.0.0 41-42|0.1.0.1.0 40-41|0.1.0.1 39-40|0.1.0.1.1 38-39|0.1.0.1.0.0.0 35-36|0.0.0.0.0.0.0 34-35|0.0.0.0.0.0 33-34|0.0.0.0.0 32-33|0.0.0.0.0.1 29-30|0.0.0.0.0.0.2.0.0+0.0.0.0.0.0.2.0+0.0.0.0.0.0.2 27-28|0.0.0.0.0.0.1.0 26-27|0.0.0.0.0.0.1.0.0 24-25|0.0.0.0.0.0.1 18-19|0 17-18|0.1 16-17|0.1.0 15-16|0.1.0.0 12-13|0.0 9-10|0.0.0 8-9|0.0.0.2.0.0+0.0.0.2.0+0.0.0.2 7-8|0.0.0.1 5-6|0.0.0.0 3-4|0.0.0.0.1 2-3|0.0.0.0.1.0 1-2|0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:13.808
(p2 / protein 
      :ARG1-of (e3 / encode-01 
            :ARG0 (g2 / gene 
                  :ARG1-of (p3 / pair-01 
                        :ARG0 (i / intron 
                              :ARG0-of (e2 / encode-01 
                                    :ARG1 (e / endonuclease) 
                                    :ARG2 (c / contain-01 
                                          :ARG1 (s2 / site 
                                                :mod (r2 / restrict-01))) 
                                    :location (t / thing 
                                          :name (n / name 
                                                :op1 "I-SceI"))) 
                              :mod (y / yeast)) 
                        :ARG1-of (c2 / contain-01 
                              :ARG0 (s3 / substrate 
                                    :mod (d2 / DNA)))) 
                  :ARG1-of (m / mutate-01) 
                  :mod (o / organization 
                        :name (n2 / name 
                              :op1 "GFP")))) 
      :mod (f / fluorescent 
            :ARG1-of (g / green-02 
                  :ARG1-of (d / detect-01) 
                  :ARG1-of (p / pair-01 
                        :ARG1-of (r / recognize-01 
                              :mod-of (s / site 
                                    :quant 18)) 
                        :mod (b / base)))))

# ::snt Transient transfection of an I-SceI expression vector results in the production of a DSB in the first mutated copy of GFP .
# ::tok Transient transfection of an I-SceI expression vector results in the production of a DSB in the first mutated copy of GFP .
# ::alignments 20-21|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 18-19|0.0.1.0+0.0.1.0.1 17-18|0.0.1.0.1.0 13-14|0.0.0.1.0+0.0.0.1+0.0.0 10-11|0.0 7-8|0+0.1 5-6|0.0.0.0 4-5|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 1-2|0.0.1 0-1|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:15.544
(r / result-01 
      :ARG1 (p / produce-01 
            :ARG0 (o2 / organization 
                  :ARG0-of (e / express-01 
                        :ARG1 (t3 / thing 
                              :name (n3 / name 
                                    :op1 "I-SceI"))) 
                  :name (n2 / name 
                        :op1 "DSB")) 
            :ARG1 (t4 / transfection 
                  :ARG0-of (c / copy-01 
                        :ARG1 (o / organization 
                              :name (n / name 
                                    :op1 "GFP")) 
                        :ARG2 (t / thing 
                              :ARG1-of (m / mutate-01))) 
                  :mod (t5 / transient))) 
      :ARG2 (t2 / thing))

# ::snt One or both DNA ends formed by the break invade ( s ) the homologous sequence in the second mutant GFP copy , resulting in repair of the DSB via a homology-mediated gene conversion event .
# ::tok One or both DNA ends formed by the break invade ( s ) the homologous sequence in the second mutant GFP copy , resulting in repair of the DSB via a homology-mediated gene conversion event .
# ::alignments 34-35|0 33-34|0.1 32-33|0.0 31-32|0.1.1.0.0.0 28-29|0.1.0.1.0+0.1.0.1+0.1.0 25-26|0.1.0.0 23-24|0.1.0.0.1 21-22|0.1.1.1+0.1.1 20-21|0.1.1.1.0.0.0+0.1.1.1.0.0+0.1.1.1.0 19-20|0.1.1.2 15-16|0.1.1.3 14-15|0.1.1.3.0 9-10|0.1.1.0.0 8-9|0.1.1.0.0.1 5-6|0.1.1.0 4-5|0.1.1.0.1 3-4|0.1.1.0.1.0 2-3|0.1.1.0.1.0.0 1-2|0.1.1.0.0.1.0 0-1|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:18.910
(e / event 
      :mod (g / gene) 
      :topic (c / convert-01 
            :ARG2 (o / organization 
                  :ARG0-of (r / repair-01 
                        :ARG1 1 
                        :ARG2-of (r2 / result-01)) 
                  :name (n / name 
                        :op1 "DSB")) 
            :mod (t / thing 
                  :ARG1-of (f / form-01 
                        :ARG0 (i / invade-01 
                              :ARG1 (h / homology-mediat) 
                              :ARG2-of (b / break-up-08 
                                    :ARG1 (o3 / or))) 
                        :ARG1-of (e2 / end-01 
                              :ARG0 (d / DNA 
                                    :mod (b2 / both)))) 
                  :ARG2-of (c2 / copy-01 
                        :ARG0 (o2 / organization 
                              :name (n2 / name 
                                    :op1 "GFP"))) 
                  :mod (m / mutant) 
                  :poss-of (s / sequence 
                        :mod (h2 / homologou)))))

# ::snt The configuration of the GFP construct is such that homology-mediated repair often results in the formation of a functional copy of GFP .
# ::tok The configuration of the GFP construct is such that homology-mediated repair often results in the formation of a functional copy of GFP .
# ::alignments 19-20|0.0.1+0.0 18-19|0 15-16|0.0.0 12-13|0.0.0.0 11-12|0.0.0.0.3 10-11|0.0.0.0.0 9-10|0.0.0.0.0.1 7-8|0.0.0.0.2 5-6|0.0.0.0.1 4-5|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 1-2|0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:19.387
(f / functional 
      :mod-of (t / thing 
            :ARG1-of (f2 / form-01 
                  :ARG2-of (r / result-01 
                        :ARG1 (r2 / repair-01 
                              :ARG1 (o2 / organization 
                                    :name (n / name 
                                          :op1 "GFP") 
                                    :poss-of (c3 / configuration)) 
                              :mod (h / homology-mediat)) 
                        :ARG1-of (c2 / construct-01) 
                        :domain-of (s / such) 
                        :frequency (o / often))) 
            :ARG2-of (c / copy-01)))

# ::snt Such events can be detected by fluorescence-activated cell sorting analysis by virtue of their expression of GFP .
# ::tok Such events can be detected by fluorescence-activated cell sorting analysis by virtue of their expression of GFP .
# ::alignments 16-17|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 14-15|0.0.0.0 11-12|0.0.0 9-10|0.0.2 8-9|0.0.2.0 7-8|0.0.2.0.0 6-7|0.0.2.1 4-5|0.0 2-3|0 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:21.474
(p / possible-01 
      :ARG1 (d / detect-01 
            :ARG0 (v / virtue 
                  :poss (e / express-01 
                        :ARG1 (o / organization 
                              :name (n / name 
                                    :op1 "GFP")))) 
            :ARG1 (e2 / event 
                  :mod (s2 / such)) 
            :manner (a / analyze-01 
                  :ARG1 (s / sort-01 
                        :ARG1 (c / cell)) 
                  :manner (f / fluorescence-activat))))

# ::snt Moynahan et al [ 24 ] have used such a GFP recombination substrate to demonstrate that cells with defective BRCA2 protein are deficient in their ability to repair the I-SceI-induced DSB through homologous recombination .
# ::tok Moynahan et al [ 24 ] have used such a GFP recombination substrate to demonstrate that cells with defective BRCA2 protein are deficient in their ability to repair the I-SceI-induced DSB through homologous recombination .
# ::alignments 33-34|0.0.0.2.2 32-33|0.0.0.2.3 30-31|0.0.0.2.0.1.0+0.0.0.2.0.1+0.0.0.2.0 29-30|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 27-28|0.0.0.2.0.0 25-26|0.0.0.2.0.0.0 22-23|0.0.0.1 20-21|0 19-20|0.0 18-19|0.1 16-17|0.0.0.1.0 14-15|0.0.0 12-13|0.0.0.2.1 11-12|0.0.0.2.1.0 10-11|0.0.0.2.1.0.0.0.0.0+0.0.0.2.1.0.0.0.0+0.0.0.2.1.0.0.0 8-9|0.0.0.2.1.0.0 7-8|0.0.0.2 4-5|0.0.0.2.0.0.1 0-3|0.0.0.2.0.0.2.0.2+0.0.0.2.0.0.2.0.1+0.0.0.2.0.0.2.0.0+0.0.0.2.0.0.2.0+0.0.0.2.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:26.302
(p / protein 
      :mod (b / BRCA2 
            :ARG2-of (d3 / demonstrate-01 
                  :ARG0 (t / thing 
                        :name (n2 / name 
                              :op1 "I-SceI-induced")) 
                  :ARG1 (d / deficient 
                        :domain (c / cell)) 
                  :ARG2-of (u / use-01 
                        :ARG0 (o / organization 
                              :ARG1-of (r2 / repair-01 
                                    :ARG0 (a / ability) 
                                    :op1-of 24 
                                    :op1-of (t2 / thing 
                                          :name (n4 / name 
                                                :op1 "Moynahan" 
                                                :op2 "et" 
                                                :op3 "al"))) 
                              :name (n / name 
                                    :op1 "DSB")) 
                        :ARG1 (s / substrate 
                              :mod (r3 / recombination 
                                    :manner (s2 / such 
                                          :manner-of (o2 / organization 
                                                :name (n3 / name 
                                                      :op1 "GFP"))))) 
                        :op1-of (r / recombination) 
                        :op1-of (h / homologou)))) 
      :mod (d2 / defective))

# ::snt Expression of I-SceI resulted in 1 out of 1400 cells producing GFP via homologous recombination in the human pancreatic tumor cell line CAPAN-1 .
# ::tok Expression of I-SceI resulted in 1 out of 1400 cells producing GFP via homologous recombination in the human pancreatic tumor cell line CAPAN-1 .
# ::alignments 21-22|0.1.1 20-21|0.1 19-20|0.1.0.1 18-19|0.1.0.0 17-18|0.1.0 14-15|0.2.3 13-14|0.2.3.0 11-12|0.2.1.0.0+0.2.1.0+0.2.1 10-11|0.2 9-10|0.2.0 8-9|0.1.1.0 5-6|0.2.2 3-4|0 2-3|0.0.0.0.0+0.0.0.0+0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:27.497
(r2 / result-01 
      :ARG1 (e / expression 
            :poss (t2 / thing 
                  :name (n2 / name 
                        :op1 "I-SceI"))) 
      :ARG2 (c / cell 
            :mod (h / human 
                  :mod-of (p / pancreatic) 
                  :mod-of (t / tumor)) 
            :mod-of (l / line 
                  :poss-of 1400)) 
      :purpose (p2 / produce-01 
            :ARG0 (c2 / cell) 
            :ARG1 (o / organization 
                  :name (n / name 
                        :op1 "GFP")) 
            :ARG2 1 
            :ARG3 (r / recombination 
                  :mod (h2 / homologou))))

# ::snt CAPAN-1 cells carry a deletion of BRCA2 on one homolog and codes for a protein truncated at amino acid 1981 on the other homolog .
# ::tok CAPAN-1 cells carry a deletion of BRCA2 on one homolog and codes for a protein truncated at amino acid 1981 on the other homolog .
# ::alignments 22-23|0.0 19-20|0.3.2.0+0.3.2 18-19|0.2 17-18|0.2.0 15-16|0 14-15|0.1 11-12|0.3.3.1 10-11|0.3.3 9-10|0.3.3.0 4-5|0.3.1 2-3|0.3 1-2|0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:29.526
(t / truncate-01 
      :ARG0 (o / other) 
      :ARG1 (p / protein) 
      :ARG2 (a / acid 
            :mod (a2 / amino)) 
      :manner-of (c2 / carry-01 
            :ARG0 (c3 / cell) 
            :ARG1 (d2 / deletion) 
            :ARG2 (d / date-entity 
                  :year 1981) 
            :accompanier (a3 / and 
                  :op1 (h / homolog) 
                  :op2 (c / code))))

# ::snt The authors indicate that the level of I-SceI-induced recombination in CAPAN-1 is over 100-fold less than that seen using other ( BRCA2 + ) human tumor cell lines .
# ::tok The authors indicate that the level of I-SceI-induced recombination in CAPAN-1 is over 100-fold less than that seen using other ( BRCA2 + ) human tumor cell lines .
# ::alignments 27-28|0.1.0.0.0 26-27|0.1.0.0 25-26|0.1.0.1 24-25|0.1.0 19-20|0.0 18-19|0.1.1 17-18|0.1.1.1 14-15|0.1.2 8-9|0.1.3 7-8|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 5-6|0.1.3.0 2-3|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:30.454
(i / indicate-01 
      :ARG0 (o / other) 
      :ARG1 (a / author-01 
            :ARG0 (h / human 
                  :mod-of (c / cell 
                        :mod-of (l / line)) 
                  :mod-of (t / tumor)) 
            :ARG0-of (u / use-01 
                  :ARG1 (t2 / thing 
                        :name (n / name 
                              :op1 "I-SceI-induced")) 
                  :ARG1-of (s / see-01)) 
            :ARG1 (l2 / less) 
            :topic (r / recombination 
                  :mod-of (l3 / level))))

# ::snt The different lines examined , however , are very likely to differ genetically from CAPAN-1 cells not only at the BRCA2 locus , but also at a very large number of additional loci .
# ::tok The different lines examined , however , are very likely to differ genetically from CAPAN-1 cells not only at the BRCA2 locus , but also at a very large number of additional loci .
# ::alignments 32-33|0.0.0.1 31-32|0.0.0.1.0 29-30|0.0.0 28-29|0.0.0.0 27-28|0.0.0.0.0 24-25|0.1.5 23-24|0 21-22|0.1.4 20-21|0.1.4.0 17-18|0.1.3.0 16-17|0.1.3 15-16|0.1.2.0 12-13|0.1.2 11-12|0.1 9-10|0.1.1 8-9|0.1.1.0 3-4|0.1.0.0 2-3|0.1.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:33.669
(c / contrast-01 
      :ARG1 (d2 / differ-02 
            :ARG1 (n / number 
                  :mod (l2 / large 
                        :degree (v / very)) 
                  :quant-of (l / locus 
                        :mod (a / additional)))) 
      :ARG2 (d / differ-02 
            :ARG1 (l5 / line 
                  :ARG1-of (e / examine-01)) 
            :ARG1-of (l4 / likely-01 
                  :degree (v2 / very)) 
            :ARG2 (g / genetics 
                  :quant-of (c2 / cell)) 
            :location (- / - 
                  :polarity-of (o / only)) 
            :manner (l3 / locu 
                  :mod (b / BRCA2)) 
            :mod (a2 / also)))

# ::snt This raises the possibility that some or even all of the recombinational repair defect seen in CAPAN-1 could be due to mutations at non-BRCA2 loci .
# ::tok This raises the possibility that some or even all of the recombinational repair defect seen in CAPAN-1 could be due to mutations at non-BRCA2 loci .
# ::alignments 24-25|0.0.0.0.0 21-22|0.0.0.0 17-18|0 14-15|0.0.1 13-14|0.0 12-13|0.0.0 8-9|0.0.2 7-8|0.0.2.0 6-7|0.1 5-6|0.1.0 3-4|0.0.1.0 1-2|0.0.1.0.0 0-1|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:35.057
(p / possible-01 
      :ARG0 (d / defect-01 
            :ARG1 (r / repair-01 
                  :ARG1 (m / mutate-01 
                        :ARG1 (l / locus))) 
            :ARG1-of (s / see-01 
                  :ARG1-of (p2 / possible-01 
                        :ARG1-of (r2 / raise-01 
                              :ARG0 (t / this)))) 
            :quant (a / all 
                  :mod (e / even))) 
      :ARG1 (o / or 
            :op1 (s2 / some)))

# ::snt While Moynahan et al were careful to point out this problem , two sets of results argue against the possibility that the recombinational repair deficiency of CAPAN-1 cells is completely independent of its defect in BRCA2 .
# ::tok While Moynahan et al were careful to point out this problem , two sets of results argue against the possibility that the recombinational repair deficiency of CAPAN-1 cells is completely independent of its defect in BRCA2 .
# ::alignments 33-34|0.3 30-31|0.4+0 29-30|0.1 27-28|0.0.0 24-25|0.0 23-24|0.0.1 19-20|0.2 16-17|0.2.0 15-16|0.2.0.0.1.0+0.2.0.0.1 13-14|0.2.0.0 12-13|0.2.0.0.2 10-11|0.2.0.0.0.1.1 9-10|0.2.0.0.0.1.1.0 7-8|0.2.0.0.0.1 5-6|0.2.0.0.0 1-4|0.2.0.0.0.1.0.0.2+0.2.0.0.0.1.0.0.1+0.2.0.0.0.1.0.0.0+0.2.0.0.0.1.0.0+0.2.0.0.0.1.0 0-1|0.2.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:38.844
(d2 / depend-01 
      :ARG0 (d3 / deficiency 
            :domain (c2 / cell) 
            :mod (r / repair-01)) 
      :ARG1-of (c / complete-02) 
      :ARG1-of (p / possible-01 
            :ARG1-of (a / argue-01 
                  :ARG0 (s / set 
                        :ARG1-of (c3 / care-04 
                              :ARG1-of (w / while-01) 
                              :ARG2 (p3 / point-01 
                                    :ARG0 (t3 / thing 
                                          :name (n / name 
                                                :op1 "Moynahan" 
                                                :op2 "et" 
                                                :op3 "al")) 
                                    :ARG1 (p2 / problem 
                                          :mod (t2 / this)))) 
                        :consist-of (t / thing 
                              :ARG2-of (r2 / result-01)) 
                        :quant 2))) 
      :ARG2 (d / defect-01) 
      :polarity -)

# ::snt First , in the same study [ 24 ] , recombination in a mouse ES cell line that expresses only truncated BRCA2 protein was measured .
# ::tok First , in the same study [ 24 ] , recombination in a mouse ES cell line that expresses only truncated BRCA2 protein was measured .
# ::alignments 24-25|0.0.0 22-23|0.0 21-22|0 20-21|0.0.2 19-20|0.0.2.1 18-19|0.0.1 16-17|0.0.1.0 15-16|0.0.1.0.0 14-15|0.0.1.0.1 13-14|0.0.0.0.0.0 10-11|0.0.0.0 7-8|0.0.2.0 5-6|0.0.0.0.0 4-5|0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:41.316
(b / BRCA2 
      :mod-of (p / protein 
            :ARG0-of (m / measure-01 
                  :ARG1 (r / recombination 
                        :ARG1-of (s / study-01 
                              :ARG0 (m2 / mouse) 
                              :ARG1-of (s2 / same-01)))) 
            :ARG1-of (e / express-01 
                  :ARG0 (l / line 
                        :mod (c / cell) 
                        :mod (e2 / e))) 
            :mod (t / truncate-01 
                  :ARG1 24 
                  :mod (o / only))))

# ::snt This line was found to have lower recombination efficiency than isogenic cells expressing full-length BRCA2 ( the defect observed was about fivefold to sixfold ) .
# ::tok This line was found to have lower recombination efficiency than isogenic cells expressing full-length BRCA2 ( the defect observed was about fivefold to sixfold ) .
# ::alignments 23-24|0.0.0.1.0 21-22|0.0.0.1.1.0.0 18-19|0.0.0.1.1.0 17-18|0.0.0.1.1 14-15|0.1 13-14|0.1.0 12-13|0 11-12|0.0 8-9|0.0.0 7-8|0.0.0.2 6-7|0.0.0.1 3-4|0.0.0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:43.473
(e / express-01 
      :ARG0 (c / cell 
            :ARG1-of (e2 / efficient-01 
                  :ARG0 (l2 / line 
                        :ARG1-of (f3 / find-01) 
                        :mod (t / this)) 
                  :ARG1-of (l / low-04 
                        :ARG0 (s / sixfold) 
                        :ARG1-of (d / defect-01 
                              :ARG0-of (o / observe-01 
                                    :ARG1 (f / fivefold)))) 
                  :mod (r / recombination))) 
      :ARG1 (b / BRCA2 
            :mod (f2 / full-length)))

# ::snt Second , in an independent study , Powell was able to compare derivatives of CAPAN-1 that differed only in their ability to express full-length BRCA2 protein ( S. Powell , personal communication , 2001 ) .
# ::tok Second , in an independent study , Powell was able to compare derivatives of CAPAN-1 that differed only in their ability to express full-length BRCA2 protein ( S. Powell , personal communication , 2001 ) .
# ::alignments 33-34|0.0.0.0.1.0+0.0.0.0.1 31-32|0.0.0.1.0 30-31|0.0.0.1.0.1 27-29|0.0.0.1.0.0.0.1+0.0.0.1.0.0.0.0+0.0.0.1.0.0.0+0.0.0.1.0.0 25-26|0.1 24-25|0.1.0 23-24|0.0.0.0.0.0 22-23|0 20-21|0.3 17-18|0.0.0.0.0.1 16-17|0.0.0.0.0 12-13|0.0.0.0 11-12|0.0.0 9-10|0.0.0.1 7-8|0.0.3+0.0.2.0+0.0.2+0.0 5-6|0.0.1 4-5|0.0.1.0.0+0.0.1.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:45.028
(e / express-01 
      :ARG0 (p5 / person 
            :ARG0-of (c2 / compare-01 
                  :ARG1 (d3 / derive-01 
                        :ARG0-of (d2 / differ-01 
                              :ARG1 (f / full-length) 
                              :mod (o / only)) 
                        :ARG1 (d / date-entity 
                              :year 2001)) 
                  :ARG1-of (p4 / possible-01 
                        :ARG1-of (c / communicate-01 
                              :ARG0 (p2 / person 
                                    :name (n / name 
                                          :op1 "S." 
                                          :op2 "Powell")) 
                              :ARG1-of (p / personal-02)))) 
            :ARG0-of (s / study-01 
                  :ARG1 (d4 / depend-01 
                        :polarity -)) 
            :name (n2 / name 
                  :op1 "Powell") 
            :wiki "Colin_Powell") 
      :ARG1 (p3 / protein 
            :mod (b / BRCA2)) 
      :ARG1-of (s2 / second-01) 
      :purpose-of (a / ability))

# ::snt In these experiments , the derivative expressing full-length BRCA2 yielded 10-fold more recombinants than controls expressing only truncated BRCA2 ( S. Powell , personal communication , 2001 ) .
# ::tok In these experiments , the derivative expressing full-length BRCA2 yielded 10-fold more recombinants than controls expressing only truncated BRCA2 ( S. Powell , personal communication , 2001 ) .
# ::alignments 26-27|0.0.1.0.0+0.0.1.0 24-25|0.0.0.0.0 23-24|0.0.0.0.0.1 21-22|0.0.0.0.2+0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 17-18|0.1.0 16-17|0.2.0 15-16|0.3.0 14-15|0.3 12-13|0.1 11-12|0.0.0.0.0.0 9-10|0 8-9|0.0 7-8|0.0.2 6-7|0.0.0 5-6|0.0.1 2-3|0.2 1-2|0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:46.174
(y / yield-01 
      :ARG0 (b / BRCA2 
            :ARG1-of (e2 / express-01 
                  :ARG0 (p2 / person 
                        :ARG0-of (c / communicate-01 
                              :ARG1 (m / more) 
                              :ARG1-of (p / personal-02)) 
                        :name (n / name 
                              :op1 "Powell") 
                        :wiki "Colin_Powell")) 
            :ARG2-of (d2 / derive-01 
                  :ARG0 (d / date-entity 
                        :year 2001)) 
            :mod (f / full-length)) 
      :ARG1 (r / recombinant 
            :ARG1-of (t / truncate-01)) 
      :ARG1-of (e3 / experiment-01 
            :ARG0 (o / only) 
            :mod (t2 / this)) 
      :ARG2 (c2 / control-01 
            :ARG1-of (e / express-01)))

# ::snt While the experimental design of these experiments was somewhat different from that of Moyna-han et al [ 24 ] , the results raise the possibility that CAPAN-1 cells have more than one mutation that lowers the efficiency of recombinational repair relative to that observed in other human cell lines .
# ::tok While the experimental design of these experiments was somewhat different from that of Moyna-han et al [ 24 ] , the results raise the possibility that CAPAN-1 cells have more than one mutation that lowers the efficiency of recombinational repair relative to that observed in other human cell lines .
# ::alignments 48-49|0.1.1.0.0.3.0 47-48|0.1.1.0.0.3.0.0 46-47|0.1.1.0.0.3.0.0.0 45-46|0.1.1.0.0.3.0.1 43-44|0.1.1.0.0.3 40-41|0.1.1.0.0.1.0.0.0.0.1 39-40|0.1.1.0.0.1.0.0.0.0 36-37|0.1.1.0.0.1.0.0.0 34-35|0.1.1.0.0.1.0.0 32-33|0.1.1.0.0.1.0 29-30|0.1.1.0.0.2 27-28|0.1.0.0 24-25|0.1.1.0.0.1 22-23|0.1.1.0.0 21-22|0.1.1.0.0.0.0+0.1.1.0.0.0 17-18|0.1.1.0.0.1.0.0.0.0.0 13-16|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 11-12|0.1.1.1 9-10|0.1.1 8-9|0.1.1.2 6-7|0.1.0 5-6|0.1.0.1 3-4|0.1 2-3|0 0-1|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:54.353
(e3 / experiment-01 
      :ARG1 (t2 / thing 
            :name (n / name 
                  :op1 "Moyna-han" 
                  :op2 "et" 
                  :op3 "al")) 
      :mod-of (d2 / design-01 
            :ARG1 (e2 / experiment-01 
                  :ARG1 (c2 / cell) 
                  :mod (t4 / this)) 
            :ARG1-of (d / differ-02 
                  :ARG1-of (w / while-01 
                        :ARG0 (r3 / raise-01 
                              :ARG0 (t / thing 
                                    :ARG2-of (r4 / result-01)) 
                              :ARG1 (p / possible-01 
                                    :ARG1 (m / mutation 
                                          :ARG0-of (l2 / lower-01 
                                                :ARG1 (e / efficient-01 
                                                      :ARG1 (r2 / repair-01 
                                                            :ARG0 24 
                                                            :ARG1 (r / relative)))))) 
                              :ARG2 (m2 / more) 
                              :ARG3 (o2 / observe-01 
                                    :ARG2 (l / line 
                                          :mod (c / cell 
                                                :mod (h / human)) 
                                          :mod (o / other))))) 
                  :ARG2 (t3 / that) 
                  :degree (s / somewhat))))

# ::snt Conversely , the BRCA2 defect in CAPAN-1 could be fully responsible for the 100-fold defect in recombination if the level of BRCA2 complementation observed by Powell was incomplete .
# ::tok Conversely , the BRCA2 defect in CAPAN-1 could be fully responsible for the 100-fold defect in recombination if the level of BRCA2 complementation observed by Powell was incomplete .
# ::alignments 27-28|0.0.1.0.1.0.0+0.0.1.0.1.0 25-26|0.0.1.0.0.0.1+0.0.1.0.0.0.0.0+0.0.1.0.0.0.0+0.0.1.0.0.0 23-24|0.0.1.0.0 22-23|0.0.1.0 19-20|0.0.1.0.1 16-17|0.0.1.1 14-15|0.0.1 10-11|0.0 9-10|0.0.2 7-8|0 4-5|0.0.0 3-4|0.0.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:55.386
(p2 / possible-01 
      :ARG1 (r2 / responsible-01 
            :ARG0 (d2 / defect-01 
                  :ARG1 (b / BRCA2)) 
            :ARG1 (d / defect-01 
                  :ARG1 (c2 / complementation 
                        :ARG1-of (o / observe-01 
                              :ARG0 (p / person 
                                    :name (n / name 
                                          :op1 "Powell") 
                                    :wiki "Colin_Powell")) 
                        :mod-of (l / level 
                              :ARG1-of (c / complete-02 
                                    :polarity -))) 
                  :location (r / recombination)) 
            :manner (f / full)) 
      :mod (c3 / conversely))

# ::snt Furthermore , the discrepancy between the 100-fold difference between CAPAN-1 and the other human lines as compared with the fivefold to sixfold difference between the Brca2lex1/lex2cells and Brca2 + / + ES cells might simply be accounted for by the fact that Brca2lex1/lex2 is not a null allele .
# ::tok Furthermore , the discrepancy between the 100-fold difference between CAPAN-1 and the other human lines as compared with the fivefold to sixfold difference between the Brca2lex1/lex2cells and Brca2 + / + ES cells might simply be accounted for by the fact that Brca2lex1/lex2 is not a null allele .
# ::alignments 47-48|0.2.0.1 46-47|0.2.0.1.0 44-45|0.0.1 40-41|0.2.0.0 36-37|0.2.0 34-35|0.2.0.2 33-34|0.2 32-33|0.2.1.2 31-32|0.1 29-30|0.1.0 26-27|0 25-26|0.0.2.1.0.0+0.0.2.1.0+0.0.2.1 22-23|0.0.2 21-22|0.2.0.1.0.0 19-20|0.0.2.0 16-17|0.0 14-15|0.2.1.0.0 13-14|0.2.1.0.0.1 12-13|0.2.1.0.0.0 10-11|0.2.1 7-8|0.2.1.0 3-4|0.2.1.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:57.234
(a3 / and 
      :op1 (c2 / compare-01 
            :ARG0 (f3 / furthermore) 
            :ARG1 - 
            :ARG2 (d / differ-02 
                  :ARG0 (f2 / fivefold) 
                  :ARG1 (t / thing 
                        :name (n2 / name 
                              :op1 "Brca2lex1/lex2cells")))) 
      :op2 (e / e 
            :op1-of (s2 / slash)) 
      :op3 (p / possible-01 
            :ARG1 (a2 / account-01 
                  :ARG0 (f / fact) 
                  :ARG1 (a / allele 
                        :ARG1-of (n / null-02 
                              :ARG0 (s3 / sixfold))) 
                  :mod (s / simple)) 
            :op2-of (a4 / and 
                  :ARG1-of (d2 / differ-02 
                        :ARG2 (l / line 
                              :mod (o / other) 
                              :mod (h / human))) 
                  :domain-of (d3 / discrepancy) 
                  :op1 (c / cell))))

# ::snt Additional studies are likely to shed light on the efficiency of BRCA2-independent recombination pathways .
# ::tok Additional studies are likely to shed light on the efficiency of BRCA2-independent recombination pathways .
# ::alignments 13-14|0.0 12-13|0 11-12|0.0.1.0.0+0.0.1.0+0.0.1 9-10|0.0.0 6-7|0.0.0.0 5-6|0.0.0.0.0 3-4|0.0.0.0.0.1 1-2|0.0.0.0.0.0 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:58.092
(r / recombination 
      :mod-of (p / pathway 
            :ARG1-of (e / efficient-01 
                  :topic-of (l / light 
                        :ARG1-of (s / shed-01 
                              :ARG0 (s2 / study-01 
                                    :ARG1 (a / additional)) 
                              :ARG1-of (l2 / likely-01)))) 
            :quant (t / thing 
                  :name (n / name 
                        :op1 "BRCA2-independent"))))

# ::snt Taken together , the results indicate that BRCA2 is indeed required for high levels of recombinational repair in both human and mouse .
# ::tok Taken together , the results indicate that BRCA2 is indeed required for high levels of recombinational repair in both human and mouse .
# ::alignments 21-22|0.1.0.2.2 20-21|0.1.0.2 19-20|0.1.0.2.1 18-19|0.1.0.2.0 16-17|0.1.0.1 15-16|0.1.0.1.0 13-14|0.1.0 12-13|0.1.0.0 10-11|0.1 9-10|0.1.1 5-6|0 4-5|0.0.1+0.0 1-2|0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:58.781
(i2 / indicate-01 
      :ARG0 (t / thing 
            :ARG0-of (t3 / take-01 
                  :mod (t2 / together)) 
            :ARG2-of (r4 / result-01)) 
      :ARG1 (r3 / require-01 
            :ARG2 (l / level 
                  :ARG1-of (h2 / high-02) 
                  :mod-of (r / repair-01 
                        :ARG1 (r2 / recombinational)) 
                  :op1-of (a / and 
                        :mod (b / both) 
                        :op2 (h / human) 
                        :op3 (m / mouse))) 
            :mod (i / indeed)))

# ::snt The function of BRCA2-RAD51 interaction .
# ::tok The function of BRCA2-RAD51 interaction .
# ::alignments 4-5|0.0 3-4|0.0.0.0.0+0.0.0.0+0.0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:36:58.856
(f / function-01 
      :ARG1 (i / interact-01 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "BRCA2-RAD51"))))

# ::snt The second paper providing evidence , by Davies et al [ 26 ] , is a biochemical study of the interaction between the homologous recombinase RAD51 and a peptide consisting of one of the eight BRC repeats from human BRCA2 .
# ::tok The second paper providing evidence , by Davies et al [ 26 ] , is a biochemical study of the interaction between the homologous recombinase RAD51 and a peptide consisting of one of the eight BRC repeats from human BRCA2 .
# ::alignments 39-40|0.1.2 38-39|0.1.2.0 36-37|0.1 35-36|0.1.0.0.0+0.1.0.0+0.1.0 34-35|0.0.0.1.0.0 29-30|0 28-29|0.0 26-27|0.0.0 25-26|0.0.0.1 23-24|0.0.0.0 20-21|0.0.0.1.0 17-18|0.0.0.1.0.1 16-17|0.0.0.1.0.1.1 11-12|0.0.0.1.0.1.0.1.0 7-10|0.1.1.0.2+0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 4-5|0.0.0.1.0.1.0.1 3-4|0.0.0.1.0.1.0 2-3|0.0.0.1.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:00.703
(c / consist-01 
      :ARG1 (p / peptide 
            :op2-of (a / and 
                  :mod (h2 / homologou) 
                  :op1 (r2 / RAD51 
                        :ARG0-of (i / interact-01 
                              :ARG1 8 
                              :ARG1-of (s / study-01 
                                    :ARG0 (p2 / provide-01 
                                          :ARG0 (p3 / paper) 
                                          :ARG1 (e / evidence-01 
                                                :ARG1 26)) 
                                    :location (b2 / biochemical)))))) 
      :ARG2 (r / repeat-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "BRC")) 
            :ARG1 (t / thing 
                  :name (n2 / name 
                        :op1 "Davies" 
                        :op2 "et" 
                        :op3 "al")) 
            :source (b / BRCA2 
                  :mod (h / human))))

# ::snt Expression of a single BRC repeat ( BRC4 ) had previously been reported to act as an inhibitor of DNA repair by Chen et al [ 27 ] .
# ::tok Expression of a single BRC repeat ( BRC4 ) had previously been reported to act as an inhibitor of DNA repair by Chen et al [ 27 ] .
# ::alignments 26-27|0.0.0.0.2.0 22-25|0.0.0.0.1.0.2+0.0.0.0.1.0.1+0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 20-21|0.0.1.0 19-20|0.0.1.0.0 17-18|0.0.1 14-15|0.0 12-13|0 10-11|0.1 7-8|0.0.2.0.0+0.0.2.0+0.0.2 5-6|0.0.0.0 4-5|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 3-4|0.0.0.0.2 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:02.970
(r2 / report-01 
      :ARG1 (a / act-02 
            :ARG0 (e / expression 
                  :ARG2-of (r3 / repeat-01 
                        :ARG0 (o / organization 
                              :name (n3 / name 
                                    :op1 "BRC")) 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 "Chen" 
                                    :op2 "et" 
                                    :op3 "al")) 
                        :ARG1-of (s / single-02 
                              :ARG0 27))) 
            :ARG1 (i / inhibitor 
                  :mod-of (r / repair-01 
                        :ARG1 (d / DNA))) 
            :ARG2 (t2 / thing 
                  :name (n2 / name 
                        :op1 "BRC4"))) 
      :time (p / previous))

# ::snt These investigators showed that expression of constructs containing the BRC4 repeat in MCF-7 cells enhances the radiosensitivity of cells and blocks both the G2/M delay associated with damage and the ability of the transfected cells to assembly subnuclear RAD51 foci .
# ::tok These investigators showed that expression of constructs containing the BRC4 repeat in MCF-7 cells enhances the radiosensitivity of cells and blocks both the G2/M delay associated with damage and the ability of the transfected cells to assembly subnuclear RAD51 foci .
# ::alignments 39-40|0.1.0.0.0.1.0.0.0.0 38-39|0.1.0.0.0.1.0.0.0.0.0 37-38|0.1.0.1.0.1 36-37|0.1.0.1.0.1.0 34-35|0.1.0.1.0 33-34|0.1.0.1.0.0 30-31|0.1.0.1 28-29|0.1.0 27-28|0.1.0.0 25-26|0.1 24-25|0 23-24|0.0.0.0+0.0.0+0.0 21-22|0.1.0.0.0.0.0.1.0.0 20-21|0.1.0.0.0.0.0.0.0 19-20|0.1.0.0.0.0.0.0 18-19|0.1.0.0.0.0.0.1.0 16-17|0.1.0.0.0.0.0.1 14-15|0.1.0.0.0.0.0 13-14|0.1.0.0.0.1.0.1.1 10-11|0.1.0.0.0.1.0.1 9-10|0.1.0.0.0.1.0.1.0.0.0+0.1.0.0.0.1.0.1.0.0+0.1.0.0.0.1.0.1.0 7-8|0.1.0.0.0.1.0 6-7|0.1.0.0.0.1.0.0 4-5|0.1.0.0.0.1.0.0.0 2-3|0.1.0.0.0.0 1-2|0.1.0.0.0.1+0.1.0.0.0 0-1|0.1.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:07.004
(d2 / delay-01 
      :ARG1 (t2 / thing 
            :name (n / name 
                  :op1 "G2/M")) 
      :ARG1-of (a4 / associate-01 
            :ARG2 (a3 / and 
                  :op1 (d / damage-01 
                        :ARG1 (p / person 
                              :ARG0-of (s2 / show-01 
                                    :ARG1 (e / enhance-01 
                                          :ARG0 (a5 / and 
                                                :op1 (b2 / block)) 
                                          :ARG1 (r2 / radiosensitivity 
                                                :domain (c2 / cell 
                                                      :op1-of (b / both))))) 
                              :ARG0-of (i / investigate-01 
                                    :ARG1 (c4 / contain-01 
                                          :ARG0 (c5 / construct 
                                                :ARG1-of (e2 / express-01 
                                                      :ARG0-of (f / focus-01 
                                                            :ARG1 (r / RAD51)))) 
                                          :ARG1 (r3 / repeat-01 
                                                :ARG1 (t3 / thing 
                                                      :name (n2 / name 
                                                            :op1 "BRC4")) 
                                                :location (c3 / cell)))) 
                              :mod (t4 / this))) 
                  :op2 (a2 / ability 
                        :domain (c / cell 
                              :mod (t / transfect) 
                              :mod-of (s / subnuclear 
                                    :mod (a / assembly)))))))

# ::snt In the paper by Davies et al , data provide evidence for a plausible mechanism of the dominant negative effect associated with expression of a single BRC repeat .
# ::tok In the paper by Davies et al , data provide evidence for a plausible mechanism of the dominant negative effect associated with expression of a single BRC repeat .
# ::alignments 27-28|0.0 26-27|0.0.0.0.0+0.0.0.0+0.0.0 25-26|0.0.1 22-23|0 20-21|0.1 19-20|0.1.0 18-19|0.1.0.2 17-18|0.1.0.1 14-15|0.1.0.0.0.0 13-14|0.1.0.0.0.0.0 10-11|0.1.0.0.0 9-10|0.1.0.0.0.1 8-9|0.1.0.0 4-7|0.1.0.0.0.1.0.0.2+0.1.0.0.0.1.0.0.1+0.1.0.0.0.1.0.0.0+0.1.0.0.0.1.0.0+0.1.0.0.0.1.0 2-3|0.1.0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:08.989
(e / express-01 
      :ARG1 (r / repeat-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "BRC")) 
            :ARG1-of (s / single-02)) 
      :ARG2-of (a / associate-01 
            :ARG1 (e2 / effect-03 
                  :ARG0 (d2 / data 
                        :ARG1-of (e3 / evidence-01 
                              :ARG0 (m / mechanism 
                                    :mod (p / plausible)) 
                              :ARG1-of (p2 / provide-01 
                                    :ARG0 (t / thing 
                                          :name (n3 / name 
                                                :op1 "Davies" 
                                                :op2 "et" 
                                                :op3 "al")) 
                                    :ARG2 (p3 / paper)))) 
                  :ARG1-of (d / dominate-01) 
                  :mod (n2 / negative))))

# ::snt DNA binding assays and electron microscopy methods were used to show that a BRC3 peptide interferes with the ability of RAD51 to assemble into oligomeric filaments on DNA .
# ::tok DNA binding assays and electron microscopy methods were used to show that a BRC3 peptide interferes with the ability of RAD51 to assemble into oligomeric filaments on DNA .
# ::alignments 27-28|0.0.0 25-26|0 22-23|0.0 18-19|0.0.1.1 15-16|0.0.1 14-15|0.0.1.0 13-14|0.0.1.0.0 10-11|0.0.1.2 8-9|0.0.1.2.0 6-7|0.0.1.2.0.0.1 5-6|0.0.1.2.0.0.1.0 4-5|0.0.1.2.0.0.1.0.0 3-4|0.0.1.2.0.0 2-3|0.0.1.2.0.0.0 1-2|0.0.1.2.0.0.0.0 0-1|0.0.1.2.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:09.869
(f / filament 
      :ARG2-of (a / assemble-01 
            :ARG1 (d / DNA) 
            :purpose-of (i / interfere-01 
                  :ARG0 (p / peptide 
                        :mod (b / BRC3)) 
                  :ARG1 (a2 / ability) 
                  :ARG1-of (s / show-01 
                        :ARG2-of (u / use-01 
                              :ARG1 (a3 / and 
                                    :op1 (a4 / assay 
                                          :ARG0-of (b2 / binding-07 
                                                :ARG1 (d2 / DNA))) 
                                    :op2 (m / method 
                                          :mod (m2 / microscopy 
                                                :mod (e / electron)))))))))

# ::snt A BRC4 peptide was also reported to inhibit the RAD51 -- DNA interaction .
# ::tok A BRC4 peptide was also reported to inhibit the RAD51 -- DNA interaction .
# ::alignments 12-13|0.0.1 11-12|0.0.1.0 7-8|0.0 5-6|0 4-5|0.1 2-3|0.0.0 1-2|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:10.529
(r / report-01 
      :ARG1 (i2 / inhibit-01 
            :ARG0 (p / peptide 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "BRC4"))) 
            :ARG1 (i / interact-01 
                  :ARG1 (d / DNA))) 
      :mod (a / also))

# ::snt These experiments raise the possibility that the full-length BRCA2 protein could act as a negative regulator of inappropriate RAD51 -- DNA interaction .
# ::tok These experiments raise the possibility that the full-length BRCA2 protein could act as a negative regulator of inappropriate RAD51 -- DNA interaction .
# ::alignments 21-22|0.1.0.3 20-21|0.1.0.3.0 18-19|0 17-18|0.0.0+0.0 15-16|0.1 14-15|0.1.1 11-12|0.1.0 10-11|0.1.0.1 9-10|0.1.0.0 8-9|0.1.0.0.0 7-8|0.1.0.0.1 4-5|0.1.0.2 2-3|0.1.0.2.0 1-2|0.1.0.2.0.0 0-1|0.1.0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:11.441
(r / RAD51 
      :ARG1-of (a / appropriate-02 
            :polarity -) 
      :mod-of (r2 / regulator 
            :ARG1-of (a2 / act-02 
                  :ARG0 (p2 / protein 
                        :mod (b / BRCA2) 
                        :mod (f / full-length)) 
                  :ARG1-of (p / possible-01) 
                  :ARG1-of (p3 / possible-01 
                        :ARG1-of (r3 / raise-01 
                              :ARG0 (e / experiment-01 
                                    :mod (t / this)))) 
                  :path (i / interact-01 
                        :ARG1 (d / DNA))) 
            :mod (n / negative)))

# ::snt The final experiment reported by Davies et al [ 26 ] is particularly important with respect to understanding the mechanism ( s ) through which BRCA2 promotes RAD51-dependent recombination .
# ::tok The final experiment reported by Davies et al [ 26 ] is particularly important with respect to understanding the mechanism ( s ) through which BRCA2 promotes RAD51-dependent recombination .
# ::alignments 28-29|0.0.0.0 26-27|0.0.0 19-20|0.0 17-18|0 15-16|0.1 13-14|0.0.0.2.0 12-13|0.0.0.2 9-10|0.0.0.1.0 5-8|0.0.0.1.1.0.0.2+0.0.0.1.1.0.0.1+0.0.0.1.1.0.0.0+0.0.0.1.1.0.0+0.0.0.1.1.0 3-4|0.0.0.1.1 2-3|0.0.0.1 1-2|0.0.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:13.248
(u / understand-01 
      :ARG1 (m / mechanism 
            :ARG0-of (p / promote-02 
                  :ARG1 (r / recombination) 
                  :ARG1-of (e / experiment-01 
                        :ARG0 26 
                        :ARG1-of (r3 / report-01 
                              :ARG0 (t / thing 
                                    :name (n / name 
                                          :op1 "Davies" 
                                          :op2 "et" 
                                          :op3 "al"))) 
                        :mod (f / final)) 
                  :op1-of (p2 / particular 
                        :mod-of (i / important)))) 
      :ARG1-of (r2 / respect-01))

# ::snt The localization of RAD51 was examined in CAPAN-1 cells , the same human tumor line examined by Moynahan et al [ 24 ] .
# ::tok The localization of RAD51 was examined in CAPAN-1 cells , the same human tumor line examined by Moynahan et al [ 24 ] .
# ::alignments 21-22|0.0.0 17-20|0.1.2+0.1.1+0.1.0+0.1+0 15-16|0.0.1.1 14-15|0.0.1 13-14|0.0.1.2 12-13|0.0.1.2.0 11-12|0.0 8-9|0.0.1.0.1 5-6|0.0.1.0 1-2|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:14.000
(t / thing 
      :ARG2-of (s / same-01 
            :ARG0 24 
            :ARG1 (l / line 
                  :ARG0-of (e2 / examine-01 
                        :ARG1 (l2 / localization) 
                        :source (c / cell)) 
                  :ARG1-of (e / examine-01) 
                  :mod (t2 / tumor 
                        :mod (h / human)))) 
      :name (n / name 
            :op1 "Moynahan" 
            :op2 "et" 
            :op3 "al"))

# ::snt It had been shown previously that the small amount of truncated BRCA2 protein expressed by CAPAN-1 cells was mislocalized to the cytoplasm , consistent with the fact that the truncation protein lacks a nuclear localization signal [ 28 ] .
# ::tok It had been shown previously that the small amount of truncated BRCA2 protein expressed by CAPAN-1 cells was mislocalized to the cytoplasm , consistent with the fact that the truncation protein lacks a nuclear localization signal [ 28 ] .
# ::alignments 37-38|0.1.1.0.0 35-36|0 34-35|0.0 33-34|0.1.1.0.1.2 31-32|0.2 30-31|0.2.0 29-30|0.2.0.0 26-27|0.1.1.0.1.1 23-24|0.1.1.0.1 21-22|0.1.1.0.1.0 16-17|0.1.0 13-14|0.1 12-13|0.1.1 11-12|0.1.1.1 10-11|0.1.1.0 8-9|0.1.1.2 7-8|0.1.1.2.0 4-5|0.1.2.1 3-4|0.1.2 0-1|0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:15.749
(s / signal-07 
      :ARG0 (l / localization) 
      :ARG1 (e / express-01 
            :ARG0 (c3 / cell) 
            :ARG1 (p2 / protein 
                  :mod (t2 / truncate-01 
                        :ARG0 28 
                        :ARG1 (c / consistent-01 
                              :ARG1 (c2 / cytoplasm) 
                              :ARG2 (f / fact) 
                              :topic (n / nucleus))) 
                  :mod (b / BRCA2) 
                  :quant (a / amount 
                        :mod (s2 / small))) 
            :ARG2-of (s3 / show-01 
                  :ARG1 (i / it) 
                  :time (p3 / previous))) 
      :ARG1-of (l2 / lack-01 
            :ARG0 (p / protein 
                  :mod (t / truncation))))

# ::snt Davies et al showed CAPAN-1 cells to be defective in nuclear localization of RAD51 , raising the possibility that RAD51 is normally carried to the nucleus by binding BRCA2 .
# ::tok Davies et al showed CAPAN-1 cells to be defective in nuclear localization of RAD51 , raising the possibility that RAD51 is normally carried to the nucleus by binding BRCA2 .
# ::alignments 28-29|0.0.0.0.0.0 27-28|0.0.0.0.0.0.0 25-26|0.0.0.0.0.2 22-23|0.0.0.0.0 21-22|0.0.0.0.0.1 17-18|0.0.0.0 15-16|0.0.0 11-12|0.0.0.0.0.0.0.0 10-11|0.0.0.0.0.0.0.0.0 8-9|0.1.0 5-6|0.1 3-4|0 0-3|0.0.1.2+0.0.1.1+0.0.1.0+0.0.1+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:16.578
(s / show-01 
      :ARG0 (t / thing 
            :ARG0-of (r / raise-01 
                  :ARG1 (p / possible-01 
                        :ARG1-of (c / carry-out-03 
                              :ARG0 (b / BRCA2 
                                    :ARG0-of (b2 / binding-07 
                                          :ARG1 (l / localization 
                                                :mod (n3 / nucleus)))) 
                              :ARG1-of (n2 / normal-02) 
                              :ARG2 (n / nucleus)))) 
            :name (n4 / name 
                  :op1 "Davies" 
                  :op2 "et" 
                  :op3 "al")) 
      :ARG1 (c2 / cell 
            :domain-of (d / defective)))

# ::snt It is possible that RAD51 may alternatively be capable of BRCA2-independent transport , but mislocalization of BRCA2 to the cytoplasm may sequester RAD51 and block its normal mode of transport .
# ::tok It is possible that RAD51 may alternatively be capable of BRCA2-independent transport , but mislocalization of BRCA2 to the cytoplasm may sequester RAD51 and block its normal mode of transport .
# ::alignments 29-30|0.1.1.1 27-28|0.1.2 26-27|0.1.2.0 24-25|0.1.1 23-24|0.1 21-22|0.1.0 20-21|0.1.0.1 19-20|0.1.0.0.0 14-15|0.1.1.0 13-14|0 11-12|0.1.0.0.2.0 10-11|0.1.0.0.2.1.0+0.1.0.0.2.1+0.1.0.0.2 8-9|0.1.0.0 6-7|0.1.0.0.3 5-6|0.1.0.0.1 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:20.972
(c2 / contrast-01 
      :ARG1 (p3 / possible-01 
            :ARG1 (i / it)) 
      :ARG2 (a / and 
            :op1 (s / sequester-01 
                  :ARG1 (c3 / capable-01 
                        :ARG1 (c / cytoplasm) 
                        :ARG1-of (p2 / possible-01) 
                        :ARG2 (t3 / thing 
                              :ARG1-of (t2 / transport-01) 
                              :name (n2 / name 
                                    :op1 "BRCA2-independent")) 
                        :mod (a2 / alternatively)) 
                  :ARG1-of (p / possible-01)) 
            :op2 (b / block-01 
                  :ARG0 (m2 / mislocalization) 
                  :ARG1 (t / transport-01)) 
            :op3 (m / mode 
                  :ARG1-of (n / normal-02))))

# ::snt Support for the hypothesis that the observed mislocalization of RAD51 is an indirect consequence of the BRCA2 defect requires reintroduction of functional BRCA2 into CAPAN-1 .
# ::tok Support for the hypothesis that the observed mislocalization of RAD51 is an indirect consequence of the BRCA2 defect requires reintroduction of functional BRCA2 into CAPAN-1 .
# ::alignments 21-23|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 19-20|0.1 18-19|0 17-18|0.0.0.0.0 16-17|0.0.0.0.0.0 13-14|0.0.0.1 12-13|0.0.0.1.0 7-8|0.0.0 6-7|0.0.0.0 3-4|0.0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:22.424
(r2 / require-01 
      :ARG0 (s / support-01 
            :ARG0 (m / mislocalization 
                  :ARG1-of (o / observe-01 
                        :ARG0-of (d / defect-01 
                              :ARG1 (b2 / BRCA2))) 
                  :domain-of (c / consequence 
                        :ARG1-of (d2 / direct-02))) 
            :ARG1 (h / hypothesi)) 
      :ARG1 (r / reintroduction 
            :poss (t / thing 
                  :name (n / name 
                        :op1 (f / functional) 
                        :op2 (b / BRCA2)))))

# ::snt Given the elaborate nature of the RAD51 -- BRCA2 interaction , it seems somewhat unlikely that the only role of BRCA2 in promoting recombination is to serve as a specific nuclear transporter of RAD51 .
# ::tok Given the elaborate nature of the RAD51 -- BRCA2 interaction , it seems somewhat unlikely that the only role of BRCA2 in promoting recombination is to serve as a specific nuclear transporter of RAD51 .
# ::alignments 31-32|0.0.0.0.0 30-31|0.0.0.0.0.0 29-30|0.0.0.0.0.1 26-27|0.0.0.0 23-24|0.0.0.2.0 22-23|0.0.0.2 18-19|0.0.0 17-18|0.0.0.1 14-15|0.0.2+0.0 13-14|0.0.1 12-13|0 9-10|0.1.0.1 8-9|0.1.0.1.0 3-4|0.1.0 2-3|0.1.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:23.117
(s4 / seem-01 
      :ARG1 (l / likely-01 
            :ARG0 (r2 / role 
                  :ARG0-of (s2 / serve-01 
                        :ARG1 (t / transport-01 
                              :ARG1 (n / nucleus) 
                              :ARG1-of (s / specific-02))) 
                  :mod (o / only) 
                  :purpose (p / promote-02 
                        :ARG1 (r / recombination))) 
            :degree (s3 / somewhat) 
            :polarity -) 
      :ARG1-of (g / give-01 
            :ARG2 (n2 / nature 
                  :mod (e / elaborate-01) 
                  :poss (i / interact-01 
                        :ARG1 (b / BRCA2)))))

# ::snt An attractive alternative , favored by Davies et al [ 26 ] , is that the association of RAD51 -- BRCA2 is required to maintain RAD51 in a form that is in a state of ` readiness ' ( Fig. 2a ) .
# ::tok An attractive alternative , favored by Davies et al [ 26 ] , is that the association of RAD51 -- BRCA2 is required to maintain RAD51 in a form that is in a state of ` readiness ' ( Fig. 2a ) .
# ::alignments 36-37|0.1.1.0.1 33-34|0.1.1.0.1.1 28-29|0.1.1.0.2 24-25|0.1.1.0 22-23|0.1.1 16-17|0.1.1.0.0 10-11|0.1.1.0.1.0 7-9|0.0.0.1+0.0.0.0+0.0.0+0.0 4-5|0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:24.619
(f2 / favor-01 
      :ARG0 (t / thing 
            :name (n / name 
                  :op1 (e / et) 
                  :op2 (a2 / al))) 
      :ARG1 (a3 / alternative 
            :ARG0-of (a4 / attract-01) 
            :ARG0-of (r2 / require-01 
                  :ARG1 (m / maintain-01 
                        :ARG0 (a / associate-01) 
                        :ARG1 (r / ready-02 
                              :ARG1 26 
                              :mod-of (s / state)) 
                        :manner (f / form)))))

# ::snt In the absence of this interaction with BRCA2 , RAD51 might exist in a form that is not capable of being recruited into a functional repair complex when damage occurs .
# ::tok In the absence of this interaction with BRCA2 , RAD51 might exist in a form that is not capable of being recruited into a functional repair complex when damage occurs .
# ::alignments 29-30|0.0.0.0.1.1 28-29|0.0.0.0.1 26-27|0.0.0.0.2 25-26|0.0.0.0.2.0 24-25|0.0.0.0.2.1 21-22|0.0.0.0 18-19|0.0.0 17-18|0.0.0.1 14-15|0.0.0.0.0 11-12|0.0 10-11|0 5-6|0.0.0.0.1.0 4-5|0.0.0.0.1.0.1 2-3|0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:25.689
(p / possible-01 
      :ARG1 (e / exist-01 
            :ARG1-of (c2 / capable-01 
                  :ARG2 (r2 / recruit-01 
                        :ARG0 (f2 / form) 
                        :ARG1 (d / damage-01 
                              :ARG1 (i / interact-01 
                                    :ARG1-of (a / absent-01) 
                                    :mod (t / this)) 
                              :ARG1-of (o / occur-01)) 
                        :ARG2 (c / complex 
                              :mod (r / repair-01) 
                              :mod (f / functional))) 
                  :polarity -)))

# ::snt For example , previous studies indicated that RAD51 shows little binding preference for single-strand DNA ( ssDNA ) over double-strand DNA ( dsDNA ) [ 3,29 ] .
# ::tok For example , previous studies indicated that RAD51 shows little binding preference for single-strand DNA ( ssDNA ) over double-strand DNA ( dsDNA ) [ 3,29 ] .
# ::alignments 20-21|0.1.0 14-15|0.1.1.1 11-12|0.1.1 10-11|0.1.1.2 9-10|0.1.1.0 8-9|0.1 5-6|0 4-5|0.0 3-4|0.0.1 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:26.578
(i / indicate-01 
      :ARG0 (s2 / study-01 
            :ARG1 (e / example) 
            :time (p2 / previous)) 
      :ARG1 (s / show-01 
            :ARG0 (d / DNA) 
            :ARG1 (p / prefer-01 
                  :ARG0 (l / little) 
                  :ARG1 (d2 / DNA) 
                  :ARG1-of (b / binding-07))))

# ::snt This result could mean that regulatory factors , such as BRCA2 , are required to suppress RAD51 -- dsDNA interactions to prevent sequestration of RAD51 in a nonfunctional form .
# ::tok This result could mean that regulatory factors , such as BRCA2 , are required to suppress RAD51 -- dsDNA interactions to prevent sequestration of RAD51 in a nonfunctional form .
# ::alignments 28-29|0.0.1.0.1.0.0.0 27-28|0.0.1.0.1.0.0.0.0 22-23|0.0.1.0.1.0.0 21-22|0.0.1.0.1.0 19-20|0.0.1.0.1 18-19|0.0.1.0.1.1 15-16|0.0.1.0 13-14|0.0.1 8-9|0.0.0 6-7|0.0.1.0.0 5-6|0.0.1.0.0.0 3-4|0 2-3|0.1 1-2|0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:27.438
(m / mean-01 
      :ARG1 (r3 / result-01 
            :ARG1 (s3 / such) 
            :ARG2 (r / require-01 
                  :ARG1 (s2 / suppress-01 
                        :ARG0 (f2 / factor 
                              :ARG0-of (r2 / regulate-01)) 
                        :ARG1 (i / interaction 
                              :ARG3 (p / prevent-01 
                                    :ARG1 (s / sequestration 
                                          :poss-of (f / form 
                                                :mod (n / nonfunctional)))) 
                              :mod (d / dsDNA)))) 
            :mod (t / this)) 
      :ARG1-of (p2 / possible-01))

# ::snt Alternatively , or in addition , suppression of RAD51 -- ssDNA interaction might be important for preventing RAD51 from binding to the regions of ssDNA that form during normal DNA replication .
# ::tok Alternatively , or in addition , suppression of RAD51 -- ssDNA interaction might be important for preventing RAD51 from binding to the regions of ssDNA that form during normal DNA replication .
# ::alignments 30-31|0.0.0.1.1 29-30|0.0.0.1.1.0 28-29|0.0.0.1 26-27|0.0.0.1.1.1 22-23|0.0.0.0.0.0 19-20|0.0.0.0.0 16-17|0.0.0.0 14-15|0.0 12-13|0 11-12|0.0.0.2 10-11|0.0.0.2.0 6-7|0.0.0 4-5|0.0.0.1.0 2-3|0.0.0.2.1 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:28.402
(p2 / possible-01 
      :ARG1 (i / important 
            :domain (s2 / suppress-01 
                  :ARG0-of (p / prevent-01 
                        :ARG1 (b / binding-07 
                              :ARG1 (r2 / region))) 
                  :ARG1 (n / normal-02 
                        :ARG0 (a / addition) 
                        :ARG1 (r / replication 
                              :mod (d / DNA) 
                              :time-of (f / form))) 
                  :purpose (i2 / interact-01 
                        :ARG1 (s / ssDNA) 
                        :op1-of (o / or)))) 
      :mod (a2 / alternatively))

# ::snt BRCA2 may thus promote RAD51 assembly into recombinational repair complexes via a negative regulatory mechanism ( i.e. by blocking RAD51 -- BRCA2 interaction until damage has occurred and factors required for ` productive ' assembly of RAD51 at damaged sites are in place ) .
# ::tok BRCA2 may thus promote RAD51 assembly into recombinational repair complexes via a negative regulatory mechanism ( i.e. by blocking RAD51 -- BRCA2 interaction until damage has occurred and factors required for ` productive ' assembly of RAD51 at damaged sites are in place ) .
# ::alignments 42-43|0.1.1.0.0 39-40|0.0.0 38-39|0.0.0.0 34-35|0.0.1 32-33|0.0.1.0 29-30|0.0 28-29|0 27-28|0.1 26-27|0.1.1 24-25|0.1.1.0 23-24|0.1.1.2 22-23|0.1.1.1 18-19|0.1.1.1.0 14-15|0.0.0.0.0.0 13-14|0.0.0.0.0 12-13|0.0.0.0.0.0.0 9-10|0.1.0.0.1 8-9|0.1.0.0.2 5-6|0.1.0.0.0 3-4|0.1.0.0 2-3|0.1.0.0.3 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:30.476
(f / factor 
      :ARG0-of (r / require-01 
            :ARG1 (s / site 
                  :ARG1-of (d / damage-01 
                        :ARG1-of (r2 / regulate-01 
                              :ARG0 (m / mechanism 
                                    :mod (n / negative))))) 
            :purpose (a / assembly 
                  :mod (p2 / productive-03))) 
      :op3-of (a2 / and 
            :op1 (p4 / possible-01 
                  :ARG1 (p3 / promote-02 
                        :ARG1 (a3 / assembly) 
                        :ARG2 (c / complex) 
                        :purpose (r3 / repair-01) 
                        :time (t / thus-far))) 
            :op2 (o / occur-01 
                  :ARG1 (d2 / damage-01 
                        :ARG1 (p / place)) 
                  :ARG1-of (i / interact-01 
                        :ARG1-of (b / block-01)) 
                  :op1-of (u / until))))

# ::snt As mentioned previously , the ability of a BRC peptide to repress the RAD51 -- BRCA2 interaction could reflect a role of full-length protein in suppressing unwanted RAD51 -- BRCA2 interactions .
# ::tok As mentioned previously , the ability of a BRC peptide to repress the RAD51 -- BRCA2 interaction could reflect a role of full-length protein in suppressing unwanted RAD51 -- BRCA2 interactions .
# ::alignments 30-31|0.0.1.0.1 26-27|0.1.0 25-26|0.0.1.0 23-24|0.0.1.1 22-23|0.0.1.1.0 20-21|0.0.1 18-19|0.0 17-18|0 16-17|0.0.1.0.0.0 15-16|0.0.1.0.0 13-14|0.0.0.0.0.0.0 11-12|0.0.0.0.0.0 9-10|0.0.0.0.0 8-9|0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 5-6|0.0.0 2-3|0.1.1 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:32.490
(p2 / possible-01 
      :ARG1 (r2 / reflect-01 
            :ARG1 (a / ability 
                  :poss (o / organization 
                        :mod-of (p3 / peptide 
                              :ARG0-of (r4 / repress-01 
                                    :ARG1 (r3 / RAD51))) 
                        :name (n / name 
                              :op1 "BRC"))) 
            :ARG2 (r / role 
                  :domain (s / suppress-01 
                        :ARG0 (b / BRCA2 
                              :ARG1-of (i2 / interact-01)) 
                        :ARG1 (i / interaction)) 
                  :poss (p / protein 
                        :mod (f / full-length)))) 
      :condition (m / mention-01 
            :ARG1 (u / unwant) 
            :time (p4 / previous)))

# ::snt Yet another potential role for BRCA2 in promoting RAD51-dependent recombinational repair is a positive role in assembly of RAD51 at damaged sites ( Fig. 2b ) .
# ::tok Yet another potential role for BRCA2 in promoting RAD51-dependent recombinational repair is a positive role in assembly of RAD51 at damaged sites ( Fig. 2b ) .
# ::alignments 23-25|0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 21-22|0.1.0.1.0.0 20-21|0.1.0.1.0 16-17|0.1.0.1 14-15|0.1.0 13-14|0.1.0.0 10-11|0.1 7-8|0 3-4|0.2 2-3|0.2.0 1-2|0.2.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:34.149
(p2 / promote-02 
      :ARG0 (y / yet) 
      :ARG1 (r2 / repair-01 
            :ARG0 (r / role 
                  :mod (p / positive) 
                  :mod (a / assembly 
                        :ARG0-of (d / damage-01 
                              :ARG1 (s / site)))) 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 (f / Fig.) 
                        :op2 2b))) 
      :purpose-of (r3 / role 
            :mod (p3 / potential) 
            :mod (a2 / another)))

# ::snt Several proteins that interact with RAD51 are thought to ` mediate ' assembly of RAD51 at sites of DNA damage ( reviewed in [ 30 ] ) .
# ::tok Several proteins that interact with RAD51 are thought to ` mediate ' assembly of RAD51 at sites of DNA damage ( reviewed in [ 30 ] ) .
# ::alignments 24-25|0.0.0.0.0 21-22|0.0.2.0.1 19-20|0.0.2.0 18-19|0.0.2.0.0 16-17|0.0.2 12-13|0.0.1 10-11|0.0 7-8|0 3-4|0.0.0.0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:35.038
(t / think-01 
      :ARG1 (m / mediate-01 
            :ARG0 (p / protein 
                  :ARG0-of (i / interact-01 
                        :ARG1 30) 
                  :quant (s2 / several)) 
            :ARG1 (a / assembly) 
            :location (s / site 
                  :consist-of (d / damage-01 
                        :ARG1 (d2 / DNA) 
                        :ARG1-of (r / review-01)))))

# ::snt RAD51 paralogs in particular , including XRCC2 , XRCC3 , RAD51B , RAD51C and RAD51D , may function as a complex that actively promotes RAD51 assembly [ 31 ] .
# ::tok RAD51 paralogs in particular , including XRCC2 , XRCC3 , RAD51B , RAD51C and RAD51D , may function as a complex that actively promotes RAD51 assembly [ 31 ] .
# ::alignments 27-28|0.0 25-26|0.1.1.0.0 23-24|0.1.1.0 22-23|0.1.1.0.1 20-21|0.1.1 17-18|0.1 16-17|0 13-14|0.2 12-13|0.2.1.0.0+0.2.1.0+0.2.1 6-7|0.2.0.0.0+0.2.0.0+0.2.0 3-4|0.1.1.0.1.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:36.493
(p2 / possible-01 
      :ARG0 31 
      :ARG1 (f / function-01 
            :ARG0 (p5 / paralog) 
            :ARG1 (c / complex 
                  :ARG0-of (p / promote-02 
                        :ARG1 (a / assembly) 
                        :ARG1-of (a2 / activity-06 
                              :mod (p4 / particular))))) 
      :op3-of (a3 / and 
            :op1 (t / thing 
                  :name (n2 / name 
                        :op1 "XRCC2")) 
            :op2 (p3 / person 
                  :name (n / name 
                        :op1 "RAD51C"))))

# ::snt BRCA2 could cooperate with RAD51 paralogs in promoting RAD51 assembly , or even provide an alternative assembly pathway .
# ::tok BRCA2 could cooperate with RAD51 paralogs in promoting RAD51 assembly , or even provide an alternative assembly pathway .
# ::alignments 17-18|0.0.2.0.0 16-17|0.0.2.0.0.0 15-16|0.0.2.0.0.1 13-14|0.0.2.0 12-13|0.0.2.0.1 11-12|0.0.2 9-10|0.0.1.0 7-8|0.0.1 5-6|0.0.0 4-5|0.0.0.0 2-3|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:36.792
(p5 / possible-01 
      :ARG1 (c / cooperate-01 
            :ARG1 (p4 / paralog 
                  :mod (r / RAD51)) 
            :ARG2 (p3 / promote-02 
                  :ARG1 (a3 / assembly)) 
            :op1-of (o / or 
                  :op2 (p2 / provide-01 
                        :ARG1 (p / pathway 
                              :mod (a / assembly) 
                              :mod (a2 / alternative)) 
                        :mod (e / even)))))

# ::snt The observation that BRCA2 localizes to damage-induced subnuclear foci with RAD51 seems consistent with the possibility that BRCA2 plays a positive role in assembly of the recombination complex [ 11 ] .
# ::tok The observation that BRCA2 localizes to damage-induced subnuclear foci with RAD51 seems consistent with the possibility that BRCA2 plays a positive role in assembly of the recombination complex [ 11 ] .
# ::alignments 29-30|0.1.2.1 27-28|0.1.2.2.0.0 26-27|0.1.2.2.0 23-24|0.1.2.0 21-22|0.1.1.0 20-21|0.1.1.0.0 18-19|0.1.1 15-16|0.1.2 12-13|0.1 11-12|0 8-9|0.0 7-8|0.0.0 6-7|0.0.1 4-5|0.1.2.2 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:39.506
(s / seem-01 
      :ARG0 (f / focus-01 
            :ARG1 (s2 / subnuclear) 
            :mod (d / damage-induc)) 
      :ARG1 (c2 / consistent-01 
            :ARG0 (o / observation) 
            :ARG1 (p2 / play-02 
                  :ARG1 (r2 / role 
                        :mod (p / positive))) 
            :ARG2 (p3 / possible-01 
                  :ARG0 (a / assembly) 
                  :ARG1 11 
                  :ARG1-of (l / localize-01 
                        :ARG0 (r / recombination 
                              :mod-of (c / complex))))))

# ::snt Finally , it is important to note that the two models for the function of the BRCA2 -- RAD51 interaction shown in Figure 2 are not mutually exclusive .
# ::tok Finally , it is important to note that the two models for the function of the BRCA2 -- RAD51 interaction shown in Figure 2 are not mutually exclusive .
# ::alignments 27-28|0.1.1.1.0 26-27|0.1.1.1.0.1 25-26|0.1.1.1.0.2 23-24|0.1.1.1.0.0 22-23|0.0 20-21|0 19-20|0.1 18-19|0.1.0 16-17|0.1.1.0 13-14|0.1.1 10-11|0.1.1.1 9-10|0.1.1.1.1 6-7|0.1.1.0.0 4-5|0.1.1.0.0.1 0-1|0.1.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:41.067
(s / show-01 
      :ARG0 (f / figure) 
      :ARG1 (i / interact-01 
            :ARG1 (r / RAD51) 
            :ARG2-of (f2 / function-01 
                  :ARG1 (b / BRCA2 
                        :ARG2-of (n / note-01 
                              :ARG0 (f3 / final) 
                              :domain-of (i2 / important))) 
                  :topic-of (m2 / model 
                        :ARG1-of (e / exclusive-02 
                              :ARG2 2 
                              :mod (m / mutual) 
                              :polarity -) 
                        :quant 2))))

# ::snt BRCA2 could prevent inappropriate RAD51 assembly in the absence of damage and promote functional RAD51 assembly at DNA lesions during the damage response .
# ::tok BRCA2 could prevent inappropriate RAD51 assembly in the absence of damage and promote functional RAD51 assembly at DNA lesions during the damage response .
# ::alignments 22-23|0.0.1.0.1 21-22|0.0.1.0.1.0 18-19|0.0.1.0.0 17-18|0.0.1.0.0.0 15-16|0.0.1.0.2 13-14|0.0.1.0.2.0 12-13|0.0.1.0 11-12|0.0.1 10-11|0.0.1.0.1.0.0 8-9|0.0.1.0.1.0.0.0 5-6|0.0.0 4-5|0.0.0.1 3-4|0.0.0.0.0+0.0.0.0 2-3|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:41.963
(p3 / possible-01 
      :ARG1 (p2 / prevent-01 
            :ARG1 (a4 / assembly 
                  :ARG1-of (a5 / appropriate-02 
                        :polarity -) 
                  :mod (r2 / RAD51)) 
            :op1-of (a2 / and 
                  :op2 (p / promote-02 
                        :ARG0 (l / lesion 
                              :mod (d2 / DNA)) 
                        :ARG0-of (r / respond-01 
                              :ARG2 (d / damage-01 
                                    :ARG1-of (d3 / damage-01 
                                          :ARG1-of (a3 / absent-01)))) 
                        :ARG1 (a / assembly 
                              :mod (f / functional))))))

# ::snt Further experiments are clearly required to clarify the functional interactions between BRCA2 and RAD51 during recombinational repair .
# ::tok Further experiments are clearly required to clarify the functional interactions between BRCA2 and RAD51 during recombinational repair .
# ::alignments 16-17|0.1.0 12-13|0.2 9-10|0.0.1 8-9|0.0.1.0 6-7|0.0 4-5|0 3-4|0.1 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:42.343
(r2 / require-01 
      :ARG1 (c / clarify-10 
            :ARG0 (e / experiment-01 
                  :mod (f2 / further)) 
            :ARG1 (i / interaction 
                  :mod (f / functional))) 
      :ARG1-of (c2 / clear-06 
            :ARG1-of (r / repair-01)) 
      :ARG2 (a / and))

# ::snt It should be relatively straightforward to determine whether the role of BRCA2 is limited to transporting RAD51 to the nucleus .
# ::tok It should be relatively straightforward to determine whether the role of BRCA2 is limited to transporting RAD51 to the nucleus .
# ::alignments 19-20|0.0.0.0.1.1 15-16|0.0.0.0.1 13-14|0.0.0.0 9-10|0.0.0.0.0 6-7|0.0.0 4-5|0.0 3-4|0.0.0.0.1.0 1-2|0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:42.793
(r3 / recommend-01 
      :ARG1 (s / straightforward 
            :domain (d / determine-01 
                  :ARG1 (l / limit-01 
                        :ARG1 (r / role) 
                        :ARG2 (t / transport-01 
                              :ARG0 (r2 / relative) 
                              :ARG1 (n / nucleus)))) 
            :domain (i / it)))

# ::snt If this were the case , addition of a nuclear localization signal to RAD51 should suppress the RAD51-mediated phenotypes associated with a BRCA2 mutation .
# ::tok If this were the case , addition of a nuclear localization signal to RAD51 should suppress the RAD51-mediated phenotypes associated with a BRCA2 mutation .
# ::alignments 23-24|0.0.0.0.1.0 22-23|0.0.0.0.1 19-20|0.0.0.0 18-19|0.0.0 17-18|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 15-16|0.0 14-15|0 11-12|0.0.0.0.0.0 10-11|0.0.0.0.0.0.0 9-10|0.0.0.0.0.0.1 6-7|0.0.0.0.0 4-5|0.0.1 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:45.554
(r / recommend-01 
      :ARG1 (s / suppress-01 
            :ARG1 (p / phenotyp 
                  :ARG1-of (a / associate-01 
                        :ARG0 (a2 / addition 
                              :poss (s2 / signal 
                                    :mod (l / localization) 
                                    :mod (n2 / nucleus))) 
                        :ARG2 (b / BRCA2 
                              :mod-of (m / mutation))) 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "RAD51-mediated"))) 
            :condition (c / case-03 
                  :domain (t2 / this))))

# ::snt However , biochemical experiments are needed to determine whether full-length BRCA2 blocks or promotes RAD51 -- BRCA2 interaction .
# ::tok However , biochemical experiments are needed to determine whether full-length BRCA2 blocks or promotes RAD51 -- BRCA2 interaction .
# ::alignments 17-18|0.0.0.0.0.0 14-15|0.0.0.1 13-14|0.0.0 12-13|0.0 11-12|0.0.0.0.0 10-11|0.0.0.0 9-10|0 7-8|0.0.0.0.0.1 5-6|0.0.0.0.0.1.0.1 3-4|0.0.0.0.0.1.0 2-3|0.0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:45.930
(f / full-length 
      :op1-of (o / or 
            :op2 (p / promote-02 
                  :ARG0 (b2 / BRCA2 
                        :ARG0-of (b / block-01 
                              :ARG1 (i / interact-01) 
                              :ARG1-of (d / determine-01 
                                    :ARG0 (e / experiment-01 
                                          :ARG1 (b3 / biochemical) 
                                          :ARG1-of (n / need-01))))) 
                  :ARG1 (r / RAD51))))

# ::snt Such experiments could also reveal additional roles for BRCA2 in recombinational repair .
# ::tok Such experiments could also reveal additional roles for BRCA2 in recombinational repair .
# ::alignments 11-12|0.1.0 10-11|0.1.0.0 8-9|0.1.0.0.0 6-7|0.1 5-6|0.1.1 4-5|0 3-4|0.3 2-3|0.2 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:46.106
(r4 / reveal-01 
      :ARG0 (e / experiment-01 
            :mod (s / such)) 
      :ARG1 (r3 / role 
            :ARG2-of (r / repair-01 
                  :ARG1 (r2 / recombinational 
                        :location-of (b / BRCA2))) 
            :mod (a / additional)) 
      :ARG1-of (p / possible-01) 
      :mod (a2 / also))

# ::snt However , several technical obstacles , including the large size of BRCA2 , promise to make biochemical characterization of BRCA2 function difficult .
# ::tok However , several technical obstacles , including the large size of BRCA2 , promise to make biochemical characterization of BRCA2 function difficult .
# ::alignments 21-22|0.0.0 20-21|0.0.1 17-18|0.0 16-17|0 13-14|0.0.0.0 9-10|0.0.1.0.0 8-9|0.0.1.0 4-5|0.0.0.0.0 3-4|0.0.0.0.0.0 2-3|0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:46.624
(b / biochemical 
      :mod-of (c / characterization 
            :domain-of (d / difficult 
                  :ARG1-of (p / promise-01 
                        :ARG0 (o / obstacle 
                              :mod (t / technical) 
                              :quant (s2 / several)))) 
            :mod (f / function-01 
                  :ARG0 (l / large 
                        :mod-of (s / size)))))

# ::snt DSB = double-strand break ; dsDNA = double-strand DNA ; ES = embryonic stem ; GFP = green fluorescent protein ; ssDNA = single-strand DNA .
# ::tok DSB = double-strand break ; dsDNA = double-strand DNA ; ES = embryonic stem ; GFP = green fluorescent protein ; ssDNA = single-strand DNA .
# ::alignments 24-25|0.0.0 19-20|0 18-19|0.1 17-18|0.0 13-14|0.2.2.0.0 12-13|0.2.2.0.0.0 10-11|0.2.2.0 8-9|0.2.1 4-5|0.2.2 3-4|0.2.0 0-1|0.2.3.0+0.2.3+0.2 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:47.145
(p / protein 
      :ARG1-of (g / green-02 
            :ARG0 (d / DNA)) 
      :mod (f / fluorescent) 
      :poss (o / organization 
            :ARG0-of (b / break-up-08) 
            :domain-of (d2 / DNA) 
            :domain-of (a / and 
                  :op1 (e2 / e 
                        :domain-of (s / stem 
                              :mod (e / embryonic)))) 
            :name (n / name 
                  :op1 "DSB")))

# ::snt Recombination substrates used for assaying homology-directed repair .
# ::tok Recombination substrates used for assaying homology-directed repair .
# ::alignments 6-7|0.0.0 5-6|0.0.0.0 2-3|0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:47.246
(s / substrat 
      :ARG1-of (u / use-01 
            :ARG2 (r / repair-01 
                  :mod (h / homology-direct))) 
      :mod (r2 / recombination))

# ::snt Cutting at the I-SceI site within the mutant GFP ( SceGFP ) results in a double-strand break that can be repaired through homologous gene conversion using a 3 ' - truncated copy of GFP as sequence donor .
# ::tok Cutting at the I-SceI site within the mutant GFP ( SceGFP ) results in a double-strand break that can be repaired through homologous gene conversion using a 3 ' - truncated copy of GFP as sequence donor .
# ::alignments 36-37|0.2.1.1.2 35-36|0.2.1.1.2.0 31-32|0.2.1.1.1.1+0.2.1.1.1 30-31|0.2.1.1.1.0 27-28|0.2.0 25-26|0.2.1.1 24-25|0.2.1.1.0 23-24|0.2.1.1.0.0 22-23|0.2.1.1.3 20-21|0.2.1 18-19|0.2.1.0 16-17|0.2 12-13|0 10-11|0.1.0.0.0+0.1.0.0+0.1.0 8-9|0.0.1.0+0.0.1+0.0 7-8|0.0.0 4-5|0.1.1 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:50.169
(r2 / result-01 
      :ARG0 (o2 / organization 
            :mod (m / mutant) 
            :name (n2 / name 
                  :op1 "GFP")) 
      :ARG1 (c3 / cut-01 
            :ARG1 (o / organization 
                  :name (n / name 
                        :op1 "SceGFP")) 
            :location (s2 / site)) 
      :ARG2 (b / break-up-08 
            :ARG1 3 
            :ARG1-of (r / repair-01 
                  :ARG1-of (p / possible-01) 
                  :manner (u / use-01 
                        :ARG0 (c2 / convert-01 
                              :ARG1 (g / gene)) 
                        :ARG1 (t / thing 
                              :ARG1-of (t2 / truncate-01) 
                              :ARG2-of (c / copy-01)) 
                        :ARG2 (d / donor 
                              :mod (s / sequence)) 
                        :mod (h / homologou)))))

# ::snt The mechanism results in the formation of a functional copy of the GFP gene .
# ::tok The mechanism results in the formation of a functional copy of the GFP gene .
# ::alignments 13-14|0.1.0.0.0 12-13|0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 9-10|0.1.0.0+0.1.0 8-9|0.1.0.1 5-6|0.1 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:50.345
(r / result-01 
      :ARG1 (m / mechanism) 
      :ARG2 (f2 / form-01 
            :ARG1 (t / thing 
                  :ARG2-of (c / copy-01 
                        :ARG1 (g / gene 
                              :mod (o / organization 
                                    :name (n / name 
                                          :op1 "GFP")))) 
                  :mod (f / functional))))

# ::snt The model shown assumes gene conversion occurs via the synthesis-dependent annealing mechanism .
# ::tok The model shown assumes gene conversion occurs via the synthesis-dependent annealing mechanism .
# ::alignments 11-12|0.1 10-11|0.1.0 6-7|0.0.0 5-6|0.0.0.0 4-5|0.0.0.1 3-4|0 2-3|0.0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:50.597
(a2 / assume-02 
      :ARG0 (m2 / model 
            :ARG0-of (o / occur-01 
                  :ARG1 (c / convert-01) 
                  :mod (g / gene)) 
            :ARG1-of (s / show-01)) 
      :ARG2 (m / mechanism 
            :mod (a / anneal)))

# ::snt Potential roles of BRCA2 in promoting assembly of Rad51 at sites of DNA damage .
# ::tok Potential roles of BRCA2 in promoting assembly of Rad51 at sites of DNA damage .
# ::alignments 13-14|0.0 12-13|0 10-11|0.0.0 8-9|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 6-7|0.0.0.0.0 5-6|0.0.0.0 3-4|0.0.0.0.1.1 1-2|0.0.0.0.1 0-1|0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:51.690
(d2 / DNA 
      :ARG1-of (d / damage-01 
            :consist (s / site 
                  :destination-of (p / promote-02 
                        :ARG1 (a / assembly 
                              :poss (t / thing 
                                    :name (n / name 
                                          :op1 "Rad51"))) 
                        :purpose-of (r / role 
                              :mod (p2 / potential) 
                              :mod (b / BRCA2))))))

# ::snt Chromosomal DNA is shown as pairs of straight lines , Rad51 as open circles , and BRCA2 as grey bars .
# ::tok Chromosomal DNA is shown as pairs of straight lines , Rad51 as open circles , and BRCA2 as grey bars .
# ::alignments 19-20|0.2.0 18-19|0.2.0.0 15-16|0.0 13-14|0.0.1 12-13|0.0.1.0 10-11|0.0.0 8-9|0.2.1 7-8|0.0.1.0.0 5-6|0.2 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:52.376
(s2 / show-01 
      :ARG0 (a / and 
            :op1 (r / Rad51) 
            :op2 (c / circle 
                  :ARG1-of (o / open-04 
                        :ARG1-of (s / straight-04)))) 
      :ARG1 (d / DNA 
            :mod (c2 / chromosomal)) 
      :ARG2 (p / pair-01 
            :ARG0 (b / bar 
                  :mod (g / grey)) 
            :ARG1 (l / line)))

# ::snt ( a ) Prevention of nonproductive DNA interactions .
# ::tok ( a ) Prevention of nonproductive DNA interactions .
# ::alignments 7-8|0.0 6-7|0.0.0 5-6|0.0.1 3-4|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:52.473
(p / prevent-01 
      :ARG1 (i / interaction 
            :mod (d / DNA) 
            :mod (n / nonproductive)))

# ::snt BRCA2 -- Rad51 interaction is proposed to suppress RAD51 -- BRCA2 interactions until DNA damage is present .
# ::tok BRCA2 -- Rad51 interaction is proposed to suppress RAD51 -- BRCA2 interactions until DNA damage is present .
# ::alignments 16-17|0.2.0.0 14-15|0.1 13-14|0.1.0 12-13|0.1.1 11-12|0.2.0 7-8|0.0 5-6|0.2 3-4|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:53.040
(i2 / interact-01 
      :ARG0-of (s / suppress-01) 
      :ARG1 (d / damage-01 
            :ARG1 (d2 / DNA) 
            :op1-of (u / until)) 
      :ARG1-of (p2 / propose-01 
            :ARG0 (i / interaction 
                  :domain-of (p / present))))

# ::snt When damage occurs , Rad51 is recruited to damaged sites where is polymerizes into nucleoprotein filaments .
# ::tok When damage occurs , Rad51 is recruited to damaged sites where is polymerizes into nucleoprotein filaments .
# ::alignments 15-16|0.1 14-15|0.1.0 12-13|0 9-10|0.0 8-9|0.0.0 6-7|0.0.1 4-5|0.0.1.0 2-3|0.0.1.1 1-2|0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:53.790
(p / polymerize-01 
      :ARG0 (s / site 
            :ARG1-of (d / damage-01) 
            :ARG4-of (r / recruit-01 
                  :ARG1 (r2 / Rad51) 
                  :condition (o / occur-01 
                        :ARG1 (d2 / damage-01)))) 
      :ARG1 (f / filament 
            :mod (n / nucleoprotein)))

# ::snt In this model , BRCA2 is not required for assembly of functional complexes at damaged sites , only to prevent a substantial fraction of Rad51 from being sequestered in a nonfunctional form .
# ::tok In this model , BRCA2 is not required for assembly of functional complexes at damaged sites , only to prevent a substantial fraction of Rad51 from being sequestered in a nonfunctional form .
# ::alignments 31-32|0.0.1.3 30-31|0.0.1.3.0 27-28|0.0.1 24-25|0.0.1.1 22-23|0.0.0 21-22|0.0.0.0 19-20|0.0 17-18|0.0.1.0 15-16|0.1.0 14-15|0.1.0.0 12-13|0.1.1 11-12|0.1.1.0 9-10|0.1 7-8|0 6-7|0.2 2-3|0.0.1.2 1-2|0.0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:55.370
(r2 / require-01 
      :ARG1 (p / prevent-01 
            :ARG1 (f2 / fraction 
                  :mod (s2 / substantial)) 
            :ARG2 (s / sequester-01 
                  :ARG0 (o / only) 
                  :ARG1 (r / Rad51) 
                  :ARG2 (m / model 
                        :mod (t / this)) 
                  :manner (f / form 
                        :mod (n / nonfunctional)))) 
      :ARG2 (a / assembly 
            :location (s3 / site 
                  :ARG1-of (d / damage-01)) 
            :mod (c / complex 
                  :mod (f3 / functional))) 
      :polarity -)

# ::snt In a BRCA2-defective cell , mutant Rad51 becomes associated with DNA at random sites and is therefore not readily recruited to sites of damage .
# ::tok In a BRCA2-defective cell , mutant Rad51 becomes associated with DNA at random sites and is therefore not readily recruited to sites of damage .
# ::alignments 23-24|0.0.1.0 21-22|0.0.1 19-20|0.0 18-19|0.0.2 17-18|0.0.2.0 14-15|0 13-14|0.0.0.0.1 12-13|0.0.1.0.0 10-11|0.0.0.1.0 8-9|0.0.0.1 7-8|0.0.0.0 6-7|0.0.0 5-6|0.0.0.2 3-4|0.0.0.0.0.0 2-3|0.0.0.0.0.1.0+0.0.0.0.0.1+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:56.390
(a / and 
      :op1 (r / recruit-01 
            :ARG0 (r4 / Rad51 
                  :ARG1-of (b / become-01 
                        :ARG0 (t / thing 
                              :location-of (c / cell) 
                              :name (n / name 
                                    :op1 "BRCA2-defective")) 
                        :location (s2 / site)) 
                  :ARG1-of (a2 / associate-01 
                        :ARG2 (d2 / DNA)) 
                  :mod (m / mutant)) 
            :ARG2 (s / site 
                  :degree-of (d / damage-01 
                        :ARG1 (r3 / random))) 
            :manner (r2 / ready-02 
                  :polarity -)))

# ::snt ( b ) Positive regulation .
# ::tok ( b ) Positive regulation .
# ::alignments 4-5|0.0 3-4|0.0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:56.440
(b / b 
      :ARG1-of (r / regulate-01 
            :degree (p / positive)))

# ::snt BRCA2 is proposed to be required for Rad51 to assemble into functional recombinational repair complexes at sites of damage .
# ::tok BRCA2 is proposed to be required for Rad51 to assemble into functional recombinational repair complexes at sites of damage .
# ::alignments 18-19|0.0.0.0.1.0 16-17|0.0.0.0.1 14-15|0.0.0 13-14|0.0 11-12|0 9-10|0.0.0.0 7-8|0.0.0.0.0 5-6|0.0.0.0.2 2-3|0.0.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:56.562
(f / functional 
      :ARG1-of (r / repair-01 
            :mod-of (c / complex 
                  :ARG2-of (a / assemble-01 
                        :ARG0 (r2 / Rad51) 
                        :ARG1 (s / site 
                              :degree-of (d / damage-01)) 
                        :purpose-of (r3 / require-01 
                              :ARG1-of (p / propose-01))))))

# ::snt In BRCA-defective cells , Rad51 fails to associate with sites of damage due to lack of an assembly factor .
# ::tok In BRCA-defective cells , Rad51 fails to associate with sites of damage due to lack of an assembly factor .
# ::alignments 18-19|0 17-18|0.1 14-15|0.0 11-12|0.0.0.0.1.0 9-10|0.0.0.0.1 7-8|0.0.0.0 5-6|0.0.0 4-5|0.0.0.0.0 2-3|0.0.0.1 1-2|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-21T19:37:56.890
(f / factor 
      :ARG1-of (l / lack-01 
            :ARG1-of (f2 / fail-01 
                  :ARG2 (a2 / associate-01 
                        :ARG1 (r / Rad51) 
                        :ARG2 (s / site 
                              :degree-of (d / damage-01))) 
                  :location (c / cell 
                        :mod (c2 / country 
                              :name (n / name 
                                    :op1 "BRCA-defective"))))) 
      :mod (a / assembly))

